person · Reporting owner

Waxman Alan

Disclosed activity across 7 companies

Tapewire entity: 1868
SEC CIK: 0001515132

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
Enstar Group LTDESGR · Entity 77648	10% owner	July 28, 2024	August 05, 2024
NEW RITE AID, LLCNONE · Entity 87704	10% owner	August 30, 2024	September 09, 2024
Sixth Street Lending PartnersNONE · Entity 1805	Vice President	September 01, 2026	September 03, 2026
Sixth Street Specialty Lending, Inc.TSLX · Entity 4591	Vice President	March 09, 2026	March 11, 2026
Sprinklr, Inc.CXM · Entity 4581	10% owner	June 22, 2021	August 27, 2021

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Enstar Group LTD

Report date July 28, 2024 · Filed August 05, 2024

Jointly reported with TSSP Sub-Fund HoldCo LLC, Elk Evergreen Investments, LLC, Elk Cypress Investments, LLC

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Ordinary SharesSEC Table I · non-derivative	IndirectHeld by Elk Evergreen Investments, LLC	355,300	Reported balance Holding disclosure · report date 2024-07-28 · row 1 Holding and transaction disclosures are not merged. 1 source row Row 1 · Balance 355,300 F1: These securities are owned directly by Elk Evergreen Investments, LLC. Elk Evergreen Investments, LLC's manager is TAO SPV GP, LLC ("TAO SPV GP"), whose sole member is TSSP Sub-Fund HoldCo, LLC, a Delaware limited liability company ("Sub-Fund HoldCo"). Sub-Fund HoldCo is managed by its sole member, whose managing member is Alan Waxman. F3: Each Reporting Person disclaims beneficial ownership over the reported securities herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its or his pecuniary interest therein.
Ordinary SharesSEC Table I · non-derivative	IndirectHeld by Elk Cypress Investments, LLC	358,900	Reported balance Holding disclosure · report date 2024-07-28 · row 2 Holding and transaction disclosures are not merged. 1 source row Row 2 · Balance 358,900 F2: These securities are owned directly by Elk Cypress Investments, LLC. Elk Cypress Investments, LLC's manager is TAO SPV GP, whose sole member is Sub-Fund HoldCo. Sub-Fund HoldCo is managed by its sole member, whose managing member is Alan Waxman. F3: Each Reporting Person disclaims beneficial ownership over the reported securities herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its or his pecuniary interest therein.

Filing footnotes · ownership attribution and instrument terms

F1: These securities are owned directly by Elk Evergreen Investments, LLC. Elk Evergreen Investments, LLC's manager is TAO SPV GP, LLC ("TAO SPV GP"), whose sole member is TSSP Sub-Fund HoldCo, LLC, a Delaware limited liability company ("Sub-Fund HoldCo"). Sub-Fund HoldCo is managed by its sole member, whose managing member is Alan Waxman.

F2: These securities are owned directly by Elk Cypress Investments, LLC. Elk Cypress Investments, LLC's manager is TAO SPV GP, whose sole member is Sub-Fund HoldCo. Sub-Fund HoldCo is managed by its sole member, whose managing member is Alan Waxman.

F3: Each Reporting Person disclaims beneficial ownership over the reported securities herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its or his pecuniary interest therein.

NEW RITE AID, LLC

Report date August 30, 2024 · Filed September 09, 2024

Jointly reported with Sixth Street Partners Management Company, L.P.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Class A UnitsSEC Table I · non-derivative	IndirectHeld by TAO Finance 3-A, LLC	82,967	Reported balance Holding disclosure · report date 2024-08-30 · row 1 Holding and transaction disclosures are not merged. 1 source row Row 1 · Balance 82,967 F1: The Form is with respect to securities of New Rite Aid, LLC ("New Rite Aid"), a successor to Rite Aid Corporation ("Old Rite Aid"). On August 16, 2024, the U.S. Bankruptcy Court for the District of New Jersey (the "Bankruptcy Court") entered an order confirming the plan of reorganization (as amended, the "Plan") of Old Rite Aid and certain of its affiliates (the "Debtors"). Pursuant to the Plan, on August 30, 2024 (the "Effective Date"), Old Rite Aid, New Rite Aid, Plan Emergence Merger Sub, Inc. ("Merger Sub"), a wholly owned subsidiary of New Rite Aid, and certain other parties entered into an agreement and plan of merger (the "Merger Agreement") pursuant to which Merger Sub merged with and into Old Rite Aid with Old Rite Aid surviving the merger and ultimately becoming a wholly owned subsidiary of New Rite Aid. In connection with the Plan, on the Effective Date, New Rite Aid issued the Class A Units described herein pursuant to the Plan in exchange for certain claims. F2: These securities are owned directly by TAO Finance 3-A, LLC, a Delaware limited liability company. Sixth Street TAO GenPar, L.P., a Delaware limited partnership, is the manager of TAO Finance 3-A, LLC, which is ultimately indirectly controlled by Sixth Street Partners Management Company, L.P., a Delaware limited partnership ("Management Company"). Management Company is managed by its general partner, whose managing member is Alan Waxman. F5: Each Reporting Person disclaims beneficial ownership over the reported securities herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of its or his pecuniary interest therein.
Class A UnitsSEC Table I · non-derivative	IndirectHeld by Conifer Finance 3, LLC	67,335	Reported balance Holding disclosure · report date 2024-08-30 · row 2 Holding and transaction disclosures are not merged. 1 source row Row 2 · Balance 67,335 F1: The Form is with respect to securities of New Rite Aid, LLC ("New Rite Aid"), a successor to Rite Aid Corporation ("Old Rite Aid"). On August 16, 2024, the U.S. Bankruptcy Court for the District of New Jersey (the "Bankruptcy Court") entered an order confirming the plan of reorganization (as amended, the "Plan") of Old Rite Aid and certain of its affiliates (the "Debtors"). Pursuant to the Plan, on August 30, 2024 (the "Effective Date"), Old Rite Aid, New Rite Aid, Plan Emergence Merger Sub, Inc. ("Merger Sub"), a wholly owned subsidiary of New Rite Aid, and certain other parties entered into an agreement and plan of merger (the "Merger Agreement") pursuant to which Merger Sub merged with and into Old Rite Aid with Old Rite Aid surviving the merger and ultimately becoming a wholly owned subsidiary of New Rite Aid. In connection with the Plan, on the Effective Date, New Rite Aid issued the Class A Units described herein pursuant to the Plan in exchange for certain claims. F3: These securities are owned directly by Conifer Finance 3, LLC, a Delaware limited liability company. Sixth Street Fundamental Strategies GenPar, L.P., a Delaware limited partnership, is the manager of Conifer Finance 3, LLC, which is ultimately indirectly controlled by Management Company. Management Company is managed by its general partner, whose managing member is Alan Waxman. F5: Each Reporting Person disclaims beneficial ownership over the reported securities herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of its or his pecuniary interest therein.
Class A UnitsSEC Table I · non-derivative	IndirectHeld by Cypress V Finance 3, LLC	14,810	Reported balance Holding disclosure · report date 2024-08-30 · row 3 Holding and transaction disclosures are not merged. 1 source row Row 3 · Balance 14,810 F1: The Form is with respect to securities of New Rite Aid, LLC ("New Rite Aid"), a successor to Rite Aid Corporation ("Old Rite Aid"). On August 16, 2024, the U.S. Bankruptcy Court for the District of New Jersey (the "Bankruptcy Court") entered an order confirming the plan of reorganization (as amended, the "Plan") of Old Rite Aid and certain of its affiliates (the "Debtors"). Pursuant to the Plan, on August 30, 2024 (the "Effective Date"), Old Rite Aid, New Rite Aid, Plan Emergence Merger Sub, Inc. ("Merger Sub"), a wholly owned subsidiary of New Rite Aid, and certain other parties entered into an agreement and plan of merger (the "Merger Agreement") pursuant to which Merger Sub merged with and into Old Rite Aid with Old Rite Aid surviving the merger and ultimately becoming a wholly owned subsidiary of New Rite Aid. In connection with the Plan, on the Effective Date, New Rite Aid issued the Class A Units described herein pursuant to the Plan in exchange for certain claims. F4: These securities are owned directly by Cypress V Finance 3, LLC, a Delaware limited liability company. Sixth Street Opportunities GenPar V, L.P., a Delaware limited partnership, is the manager of Cypress V Finance 3, LLC, which is ultimately indirectly controlled by Management Company. Management Company is managed by its general partner, whose managing member is Alan Waxman. F5: Each Reporting Person disclaims beneficial ownership over the reported securities herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of its or his pecuniary interest therein.

Filing footnotes · ownership attribution and instrument terms

F1: The Form is with respect to securities of New Rite Aid, LLC ("New Rite Aid"), a successor to Rite Aid Corporation ("Old Rite Aid"). On August 16, 2024, the U.S. Bankruptcy Court for the District of New Jersey (the "Bankruptcy Court") entered an order confirming the plan of reorganization (as amended, the "Plan") of Old Rite Aid and certain of its affiliates (the "Debtors"). Pursuant to the Plan, on August 30, 2024 (the "Effective Date"), Old Rite Aid, New Rite Aid, Plan Emergence Merger Sub, Inc. ("Merger Sub"), a wholly owned subsidiary of New Rite Aid, and certain other parties entered into an agreement and plan of merger (the "Merger Agreement") pursuant to which Merger Sub merged with and into Old Rite Aid with Old Rite Aid surviving the merger and ultimately becoming a wholly owned subsidiary of New Rite Aid. In connection with the Plan, on the Effective Date, New Rite Aid issued the Class A Units described herein pursuant to the Plan in exchange for certain claims.

F2: These securities are owned directly by TAO Finance 3-A, LLC, a Delaware limited liability company. Sixth Street TAO GenPar, L.P., a Delaware limited partnership, is the manager of TAO Finance 3-A, LLC, which is ultimately indirectly controlled by Sixth Street Partners Management Company, L.P., a Delaware limited partnership ("Management Company"). Management Company is managed by its general partner, whose managing member is Alan Waxman.

F3: These securities are owned directly by Conifer Finance 3, LLC, a Delaware limited liability company. Sixth Street Fundamental Strategies GenPar, L.P., a Delaware limited partnership, is the manager of Conifer Finance 3, LLC, which is ultimately indirectly controlled by Management Company. Management Company is managed by its general partner, whose managing member is Alan Waxman.

F4: These securities are owned directly by Cypress V Finance 3, LLC, a Delaware limited liability company. Sixth Street Opportunities GenPar V, L.P., a Delaware limited partnership, is the manager of Cypress V Finance 3, LLC, which is ultimately indirectly controlled by Management Company. Management Company is managed by its general partner, whose managing member is Alan Waxman.

F5: Each Reporting Person disclaims beneficial ownership over the reported securities herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of its or his pecuniary interest therein.

Sixth Street Lending Partners

Report date September 01, 2026 · Filed September 03, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common shares of beneficial interest, par value $0.001SEC Table I · non-derivative	IndirectSee Footnote	12,560,764	Reported balance After 2026-09-01 transaction · row 1 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 1 · 2026-09-01 · Purchase · Acquired 1,405,583 · Balance 12,560,764 F1: Shares held directly by Sixth Street Lending Partners Note Issuer, LLC ("Note Issuer"). Note Issuer is controlled by its members, which are indirectly controlled by TAO Sutton Holdings, LLC. TAO Insurance Holdings, LLC is the managing member of TAO Sutton Holdings, LLC. A. Michael Muscolino is the managing member of TAO Insurance Holdings, LLC. Pursuant to the limited liability company agreement of TAO Insurance Holdings, LLC, Reporting Person, as designated member of TAO Insurance Holdings, LLC has the authority to appoint the managing member of TAO Insurance Holdings, LLC.
Common shares of beneficial interest, par value $0.001SEC Table I · non-derivative	IndirectSee Footnote	2,255,597	Reported balance After 2026-09-01 transaction · row 2 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 2 · 2026-09-01 · Purchase · Acquired 255,924 · Balance 2,255,597 F2: Shares are held directly by Sixth Street Lending Partners Advisers, LLC ("Adviser"). Adviser is managed by TSSP HoldCo Management, LLC ("Holdco Management"). Holdco Management is managed by a board of directors, which is currently comprised of Reporting Person. Reporting Person is the CEO of Holdco Management.

Filing footnotes · ownership attribution and instrument terms

F1: Shares held directly by Sixth Street Lending Partners Note Issuer, LLC ("Note Issuer"). Note Issuer is controlled by its members, which are indirectly controlled by TAO Sutton Holdings, LLC. TAO Insurance Holdings, LLC is the managing member of TAO Sutton Holdings, LLC. A. Michael Muscolino is the managing member of TAO Insurance Holdings, LLC. Pursuant to the limited liability company agreement of TAO Insurance Holdings, LLC, Reporting Person, as designated member of TAO Insurance Holdings, LLC has the authority to appoint the managing member of TAO Insurance Holdings, LLC.

F2: Shares are held directly by Sixth Street Lending Partners Advisers, LLC ("Adviser"). Adviser is managed by TSSP HoldCo Management, LLC ("Holdco Management"). Holdco Management is managed by a board of directors, which is currently comprised of Reporting Person. Reporting Person is the CEO of Holdco Management.

Sixth Street Specialty Lending, Inc.

Report date March 09, 2026 · Filed March 11, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	IndirectBy Trust	500,000	Reported balance After 2026-03-09 transaction · row 1 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 1 · 2026-03-09 · Purchase · Acquired 200,000 · Balance 500,000 F1: The price reported in Column 4 is a weighted average price. These shares of common stock, par value $0.01 per share (the "Shares") were purchased in multiple transactions at prices ranging from $17.865 to $18.445, inclusive. Mr. Waxman ("Reporting Person") undertakes to provide to Sixth Street Specialty Lending, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price within the range set forth above.
Common StockSEC Table I · non-derivative	IndirectBy Trust	545,000	Reported balance After 2026-03-10 transaction · row 2 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 2 · 2026-03-10 · Purchase · Acquired 45,000 · Balance 545,000 F2: The price reported in Column 4 is a weighted average price. These Shares were purchased in multiple transactions at prices ranging from $18.27 to $18.57, inclusive. Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price within the range set forth above.
Common StockSEC Table I · non-derivative	IndirectSee Footnote	2,714,266	Reported balance Holding disclosure · report date 2026-03-09 · row 3 Holding and transaction disclosures are not merged. 1 source row Row 3 · Balance 2,714,266 F3: Shares are held directly by Sixth Street Specialty Lending Advisers, LLC ("Adviser"). Adviser is managed by Sixth Street Specialty Lending Advisers Holdings, LLC, the sole member of Adviser. Sixth Street Specialty Lending Advisers Holdings, LLC is managed by TSSP Holdco Management, LLC, which is managed by a board of directors, which is currently comprised of Reporting Person. Reporting Person is the CEO of TSSP Holdco Management, LLC.

Filing footnotes · ownership attribution and instrument terms

F1: The price reported in Column 4 is a weighted average price. These shares of common stock, par value $0.01 per share (the "Shares") were purchased in multiple transactions at prices ranging from $17.865 to $18.445, inclusive. Mr. Waxman ("Reporting Person") undertakes to provide to Sixth Street Specialty Lending, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price within the range set forth above.

F2: The price reported in Column 4 is a weighted average price. These Shares were purchased in multiple transactions at prices ranging from $18.27 to $18.57, inclusive. Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price within the range set forth above.

F3: Shares are held directly by Sixth Street Specialty Lending Advisers, LLC ("Adviser"). Adviser is managed by Sixth Street Specialty Lending Advisers Holdings, LLC, the sole member of Adviser. Sixth Street Specialty Lending Advisers Holdings, LLC is managed by TSSP Holdco Management, LLC, which is managed by a board of directors, which is currently comprised of Reporting Person. Reporting Person is the CEO of TSSP Holdco Management, LLC.

Sprinklr, Inc.

Report date June 22, 2021 · Filed August 27, 2021

Jointly reported with Sixth Street Partners Management Company, L.P., Sixth Street Specialty Lending, Inc.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Class B Common StockSEC Table II · derivative / convertible security	IndirectHeld by Palette Investments, LLC	Not disclosed	Reported balance Holding disclosure · report date 2021-06-22 · row 1 Instrument identity requires review; Table II rows are not merged. 1 source row Row 1 · Balance Not disclosed F1: Each share of the Company's Class B Common Stock is convertible into a share of the Company's Class A Common stock on a 1-to-1 basis and has no expiration date. F2: These shares are owned directly by Palette Investments, LLC. Palette Investments, LLC is owned by each of (i) TCS Finance (A), LLC, a Delaware limited liability company, (ii) TCS Finance 1, LLC, a Delaware limited liability company and (iii) Palette IV Holdings, LLC, a Delaware limited liability company. Sixth Street Capital Solutions GenPar, L.P., a Delaware limited partnership, is the manager of TCS Finance (A), LLC and TCS Finance 1, LLC. Sixth Street Opportunities GenPar IV, L.P., a Delaware limited partnership, is the manager of Palette IV Holdings, LLC. F3: Each of Sixth Street Opportunities GenPar IV, L.P. and Sixth Street Capital Solutions GenPar, L.P. is ultimately indirectly controlled by Sixth Street Partners Management Company, L.P., a Delaware limited partnership ("Management Company"). Management Company is managed by its general partner, whose managing member is Alan Waxman. Because of the relationship between Mr. Waxman and Palette Investments, LLC, he may be deemed to beneficially own the shares of the Company's Class B Common Stock owned by Palette Investments, LLC. F5: Each reporting person disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its or his pecuniary interest therein.
Class B Common StockSEC Table II · derivative / convertible security	IndirectHeld by Sixth Street Specialty Lending, Inc.	Not disclosed	Reported balance Holding disclosure · report date 2021-06-22 · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · Balance Not disclosed F1: Each share of the Company's Class B Common Stock is convertible into a share of the Company's Class A Common stock on a 1-to-1 basis and has no expiration date. F4: These shares are owned directly by Sixth Street Specialty Lending, Inc., a Delaware corporation ("SLX"). SLX is managed by Sixth Street Specialty Lending Advisers, LLC, a Delaware limited liability company ("Adviser"). The business and affairs of Adviser are managed by Sixth Street Specialty Lending Advisers Holdings, LLC, a Delaware limited liability company, the sole member of Adviser ("Adviser Holdings"). Adviser Holdings is managed by TSSP Holdco Management, LLC, a Delaware limited liability company ("TSSP Holdco Management"). TSSP Holdco Management is managed by a board of directors, which is currently comprised of Mr. Waxman. Mr. Waxman is the CEO and Managing Partner of TSSP Holdco Management. Because Mr. Waxman is a member of the board of directors of TSSP Holdco Management, he may be deemed to beneficially own the shares of the Company's Class B Common Stock owned by SLX. F5: Each reporting person disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its or his pecuniary interest therein.

Filing footnotes · ownership attribution and instrument terms

F1: Each share of the Company's Class B Common Stock is convertible into a share of the Company's Class A Common stock on a 1-to-1 basis and has no expiration date.

F2: These shares are owned directly by Palette Investments, LLC. Palette Investments, LLC is owned by each of (i) TCS Finance (A), LLC, a Delaware limited liability company, (ii) TCS Finance 1, LLC, a Delaware limited liability company and (iii) Palette IV Holdings, LLC, a Delaware limited liability company. Sixth Street Capital Solutions GenPar, L.P., a Delaware limited partnership, is the manager of TCS Finance (A), LLC and TCS Finance 1, LLC. Sixth Street Opportunities GenPar IV, L.P., a Delaware limited partnership, is the manager of Palette IV Holdings, LLC.

F3: Each of Sixth Street Opportunities GenPar IV, L.P. and Sixth Street Capital Solutions GenPar, L.P. is ultimately indirectly controlled by Sixth Street Partners Management Company, L.P., a Delaware limited partnership ("Management Company"). Management Company is managed by its general partner, whose managing member is Alan Waxman. Because of the relationship between Mr. Waxman and Palette Investments, LLC, he may be deemed to beneficially own the shares of the Company's Class B Common Stock owned by Palette Investments, LLC.

F4: These shares are owned directly by Sixth Street Specialty Lending, Inc., a Delaware corporation ("SLX"). SLX is managed by Sixth Street Specialty Lending Advisers, LLC, a Delaware limited liability company ("Adviser"). The business and affairs of Adviser are managed by Sixth Street Specialty Lending Advisers Holdings, LLC, a Delaware limited liability company, the sole member of Adviser ("Adviser Holdings"). Adviser Holdings is managed by TSSP Holdco Management, LLC, a Delaware limited liability company ("TSSP Holdco Management"). TSSP Holdco Management is managed by a board of directors, which is currently comprised of Mr. Waxman. Mr. Waxman is the CEO and Managing Partner of TSSP Holdco Management. Because Mr. Waxman is a member of the board of directors of TSSP Holdco Management, he may be deemed to beneficially own the shares of the Company's Class B Common Stock owned by SLX.

F5: Each reporting person disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its or his pecuniary interest therein.

Past disclosures · reporting ended (2)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

AvePoint, Inc.

Report date September 15, 2023 · Filed September 18, 2023

Jointly reported with Sixth Street Partners Management Company, L.P.

Section 16 reporting ended · disclosed 2023-09-18. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	IndirectHeld by Avatar Investment Solutions (A), LLC	2,407,123	Reported balance After 2023-09-15 transaction · row 1 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 1 · 2023-09-15 · Sale · Disposed 4,984,140 · Balance 2,407,123 F1: Includes 213,895 shares of Common Stock that the Reporting Persons have the right to receive if the trading price of the Common Stock reaches certain thresholds (the "Contingent Consideration"). F2: The Contingent Consideration vests in equal thirds if the trading price of Common Stock is greater than or equal to $12.50, $15.00 and $17.50, respectively, for any 20 trading days within any 30-trading day period (the "Milestones"). If the Milestones are not met by the seventh anniversary of the closing of the issuer's initial public offering, then the unvested Contingent Consideration will be forfeited. F3: These shares are owned directly by Avatar Investment Solutions (A), LLC. Avatar Investment Solutions (A), LLC's managing member is TCS Finance (A), LLC, the managing member of which is Sixth Street Growth GenPar, L.P. (formerly known as TSSP Capital Solutions GenPar, L.P.), a Delaware limited partnership. Sixth Street Growth GenPar, L.P. is ultimately indirectly controlled by Sixth Street Partners Management Company, L.P., a Delaware limited partnership ("Management Company"). Management Company is managed by its general partner, whose managing member is Alan Waxman. F8: Each of Management Company and Alan Waxman disclaim beneficial ownership over the reported securities, except to the extent of their pecuniary interest therein.
Common StockSEC Table I · non-derivative	IndirectHeld by Avatar Investment Solutions 1, LLC	1,885,806	Reported balance After 2023-09-15 transaction · row 2 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 2 · 2023-09-15 · Sale · Disposed 3,904,714 · Balance 1,885,806 F2: The Contingent Consideration vests in equal thirds if the trading price of Common Stock is greater than or equal to $12.50, $15.00 and $17.50, respectively, for any 20 trading days within any 30-trading day period (the "Milestones"). If the Milestones are not met by the seventh anniversary of the closing of the issuer's initial public offering, then the unvested Contingent Consideration will be forfeited. F4: Includes 167,571 shares of Contingent Consideration. F5: These shares are owned directly by Avatar Investment Solutions 1, LLC. Avatar Investment Solutions 1, LLC's managing member is TCS Finance 1, LLC, the manager of which is Sixth Street Growth GenPar, L.P. Sixth Street Growth GenPar, L.P. is ultimately indirectly controlled by Management Company. Management Company is managed by its general partner, whose managing member is Alan Waxman. F8: Each of Management Company and Alan Waxman disclaim beneficial ownership over the reported securities, except to the extent of their pecuniary interest therein.
Common StockSEC Table I · non-derivative	IndirectHeld by Avatar Investment Opportunities, LLC	3,756,312	Reported balance After 2023-09-15 transaction · row 3 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 3 · 2023-09-15 · Sale · Disposed 7,777,746 · Balance 3,756,312 F2: The Contingent Consideration vests in equal thirds if the trading price of Common Stock is greater than or equal to $12.50, $15.00 and $17.50, respectively, for any 20 trading days within any 30-trading day period (the "Milestones"). If the Milestones are not met by the seventh anniversary of the closing of the issuer's initial public offering, then the unvested Contingent Consideration will be forfeited. F6: Includes 333,783 shares of Contingent Consideration. F7: These shares are owned directly by Avatar Investment Opportunities, LLC. Avatar Investment Opportunities, LLC's managing member is Redwood IV Finance 1, LLC, the managing member of which is Sixth Street Opportunities GenPar IV, L.P. (formerly known as TSSP Opportunities GenPar IV, L.P.). Sixth Street Opportunities GenPar IV, L.P. is ultimately indirectly controlled by Management Company. Management Company is managed by its general partner, whose managing member is Alan Waxman. F8: Each of Management Company and Alan Waxman disclaim beneficial ownership over the reported securities, except to the extent of their pecuniary interest therein.

Filing footnotes · ownership attribution and instrument terms

F1: Includes 213,895 shares of Common Stock that the Reporting Persons have the right to receive if the trading price of the Common Stock reaches certain thresholds (the "Contingent Consideration").

F2: The Contingent Consideration vests in equal thirds if the trading price of Common Stock is greater than or equal to $12.50, $15.00 and $17.50, respectively, for any 20 trading days within any 30-trading day period (the "Milestones"). If the Milestones are not met by the seventh anniversary of the closing of the issuer's initial public offering, then the unvested Contingent Consideration will be forfeited.

F3: These shares are owned directly by Avatar Investment Solutions (A), LLC. Avatar Investment Solutions (A), LLC's managing member is TCS Finance (A), LLC, the managing member of which is Sixth Street Growth GenPar, L.P. (formerly known as TSSP Capital Solutions GenPar, L.P.), a Delaware limited partnership. Sixth Street Growth GenPar, L.P. is ultimately indirectly controlled by Sixth Street Partners Management Company, L.P., a Delaware limited partnership ("Management Company"). Management Company is managed by its general partner, whose managing member is Alan Waxman.

F4: Includes 167,571 shares of Contingent Consideration.

F5: These shares are owned directly by Avatar Investment Solutions 1, LLC. Avatar Investment Solutions 1, LLC's managing member is TCS Finance 1, LLC, the manager of which is Sixth Street Growth GenPar, L.P. Sixth Street Growth GenPar, L.P. is ultimately indirectly controlled by Management Company. Management Company is managed by its general partner, whose managing member is Alan Waxman.

F6: Includes 333,783 shares of Contingent Consideration.

F7: These shares are owned directly by Avatar Investment Opportunities, LLC. Avatar Investment Opportunities, LLC's managing member is Redwood IV Finance 1, LLC, the managing member of which is Sixth Street Opportunities GenPar IV, L.P. (formerly known as TSSP Opportunities GenPar IV, L.P.). Sixth Street Opportunities GenPar IV, L.P. is ultimately indirectly controlled by Management Company. Management Company is managed by its general partner, whose managing member is Alan Waxman.

F8: Each of Management Company and Alan Waxman disclaim beneficial ownership over the reported securities, except to the extent of their pecuniary interest therein.

Caris Life Sciences, Inc.

Report date June 20, 2025 · Filed June 23, 2025

Jointly reported with TSSP Sub-Fund HoldCo LLC

Section 16 reporting ended · disclosed 2025-06-23. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	IndirectHeld by Barnett Equity Holdings, LLC	5,687,176	Last balance in matching sequence After 2025-06-20 transaction · row 9 Source-order balances reconcile. Account continuity and personal attribution are not independently verified. 3 source rows Row 1 · 2025-06-20 · Conversion · Acquired 1,721,015 · Balance 1,721,015 F1: Each share of Series C Preferred Stock of Caris Life Sciences, Inc. (the "Issuer") was convertible at the option of the holder into 0.25 shares of common stock $.001 par value of the Issuer (the "Common Stock") and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's initial public offering (the "IPO"). The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's amended and restated certificate of formation (the "Charter"), in connection with the IPO. The Series C Preferred Stock had no expiration date. F5: TSSP Sub-Fund Holdco, LLC, a Delaware limited liability company ("Sub-Fund HoldCo"), is the sole member of each of TAO SPV GP, LLC, a Delaware limited liability company ("TAO SPV"), and Empire SPV GP, LLC, a Delaware limited liability company ("Empire SPV"). TAO SPV is the managing member of each of (i) Barnett Equity Holdings, LLC; (ii) Barnett Equity Holdings II LLC; and (iii) TAO Barnett Investments LLC. Empire SPV is the managing member of TOP III Barnett Investments, LLC. F7: Sub-Fund HoldCo is managed by its sole member, whose managing member is Alan Waxman ("Mr. Waxman"). Holdco Management is managed by a board of directors, which is currently comprised of Mr. Waxman. Mr. Waxman is the CEO of Holdco Management. Each Reporting Person disclaims beneficial ownership over the reported securities herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of its or his pecuniary interest therein. Row 7 · 2025-06-20 · Other · Acquired 2,255,048 · Balance 3,976,063 F3: The 2018 warrants were exercisable at the option of the holder into shares of Series C Preferred Stock of the Issuer at an exercise price of $1.61 per share and into Common Stock at an exercise price of $6.44 per share. Immediately prior to and in connection with the closing of the Issuer's IPO, the 2018 warrants were exercised on a cashless basis into shares of Series C Preferred Stock which then automatically converted into Common Stock. The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO. F5: TSSP Sub-Fund Holdco, LLC, a Delaware limited liability company ("Sub-Fund HoldCo"), is the sole member of each of TAO SPV GP, LLC, a Delaware limited liability company ("TAO SPV"), and Empire SPV GP, LLC, a Delaware limited liability company ("Empire SPV"). TAO SPV is the managing member of each of (i) Barnett Equity Holdings, LLC; (ii) Barnett Equity Holdings II LLC; and (iii) TAO Barnett Investments LLC. Empire SPV is the managing member of TOP III Barnett Investments, LLC. F7: Sub-Fund HoldCo is managed by its sole member, whose managing member is Alan Waxman ("Mr. Waxman"). Holdco Management is managed by a board of directors, which is currently comprised of Mr. Waxman. Mr. Waxman is the CEO of Holdco Management. Each Reporting Person disclaims beneficial ownership over the reported securities herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of its or his pecuniary interest therein. Row 9 · 2025-06-20 · Other · Acquired 1,711,113 · Balance 5,687,176 F4: The 2020 warrants were exercisable into Series C preferred stock at a price of $1.93 per share and into Common Stock at a price of $7.73 per share. Immediately prior to and in connection with the closing of the Issuer's IPO the 2020 warrants were exercised on a cashless basis into shares of Series C Preferred Stock which then automatically converted into Common Stock. The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO. F5: TSSP Sub-Fund Holdco, LLC, a Delaware limited liability company ("Sub-Fund HoldCo"), is the sole member of each of TAO SPV GP, LLC, a Delaware limited liability company ("TAO SPV"), and Empire SPV GP, LLC, a Delaware limited liability company ("Empire SPV"). TAO SPV is the managing member of each of (i) Barnett Equity Holdings, LLC; (ii) Barnett Equity Holdings II LLC; and (iii) TAO Barnett Investments LLC. Empire SPV is the managing member of TOP III Barnett Investments, LLC. F7: Sub-Fund HoldCo is managed by its sole member, whose managing member is Alan Waxman ("Mr. Waxman"). Holdco Management is managed by a board of directors, which is currently comprised of Mr. Waxman. Mr. Waxman is the CEO of Holdco Management. Each Reporting Person disclaims beneficial ownership over the reported securities herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of its or his pecuniary interest therein.
Common StockSEC Table I · non-derivative	IndirectHeld by TOP III Barnett Investments, LLC	3,881,988	Reported balance After 2025-06-20 transaction · row 2 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 2 · 2025-06-20 · Conversion · Acquired 3,881,988 · Balance 3,881,988 F1: Each share of Series C Preferred Stock of Caris Life Sciences, Inc. (the "Issuer") was convertible at the option of the holder into 0.25 shares of common stock $.001 par value of the Issuer (the "Common Stock") and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's initial public offering (the "IPO"). The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's amended and restated certificate of formation (the "Charter"), in connection with the IPO. The Series C Preferred Stock had no expiration date. F5: TSSP Sub-Fund Holdco, LLC, a Delaware limited liability company ("Sub-Fund HoldCo"), is the sole member of each of TAO SPV GP, LLC, a Delaware limited liability company ("TAO SPV"), and Empire SPV GP, LLC, a Delaware limited liability company ("Empire SPV"). TAO SPV is the managing member of each of (i) Barnett Equity Holdings, LLC; (ii) Barnett Equity Holdings II LLC; and (iii) TAO Barnett Investments LLC. Empire SPV is the managing member of TOP III Barnett Investments, LLC. F7: Sub-Fund HoldCo is managed by its sole member, whose managing member is Alan Waxman ("Mr. Waxman"). Holdco Management is managed by a board of directors, which is currently comprised of Mr. Waxman. Mr. Waxman is the CEO of Holdco Management. Each Reporting Person disclaims beneficial ownership over the reported securities herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of its or his pecuniary interest therein.
Common StockSEC Table I · non-derivative	IndirectHeld by TAO Barnett Investments LLC	3,493,789	Reported balance After 2025-06-20 transaction · row 3 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 3 · 2025-06-20 · Conversion · Acquired 3,493,789 · Balance 3,493,789 F1: Each share of Series C Preferred Stock of Caris Life Sciences, Inc. (the "Issuer") was convertible at the option of the holder into 0.25 shares of common stock $.001 par value of the Issuer (the "Common Stock") and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's initial public offering (the "IPO"). The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's amended and restated certificate of formation (the "Charter"), in connection with the IPO. The Series C Preferred Stock had no expiration date. F5: TSSP Sub-Fund Holdco, LLC, a Delaware limited liability company ("Sub-Fund HoldCo"), is the sole member of each of TAO SPV GP, LLC, a Delaware limited liability company ("TAO SPV"), and Empire SPV GP, LLC, a Delaware limited liability company ("Empire SPV"). TAO SPV is the managing member of each of (i) Barnett Equity Holdings, LLC; (ii) Barnett Equity Holdings II LLC; and (iii) TAO Barnett Investments LLC. Empire SPV is the managing member of TOP III Barnett Investments, LLC. F7: Sub-Fund HoldCo is managed by its sole member, whose managing member is Alan Waxman ("Mr. Waxman"). Holdco Management is managed by a board of directors, which is currently comprised of Mr. Waxman. Mr. Waxman is the CEO of Holdco Management. Each Reporting Person disclaims beneficial ownership over the reported securities herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of its or his pecuniary interest therein.
Common StockSEC Table I · non-derivative	IndirectHeld by Sixth Street Specialty Lending, Inc.	1,219,271	Last balance in matching sequence After 2025-06-20 transaction · row 10 Source-order balances reconcile. Account continuity and personal attribution are not independently verified. 4 source rows Row 4 · 2025-06-20 · Conversion · Acquired 478,779 · Balance 478,779 F1: Each share of Series C Preferred Stock of Caris Life Sciences, Inc. (the "Issuer") was convertible at the option of the holder into 0.25 shares of common stock $.001 par value of the Issuer (the "Common Stock") and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's initial public offering (the "IPO"). The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's amended and restated certificate of formation (the "Charter"), in connection with the IPO. The Series C Preferred Stock had no expiration date. F6: TSSP Holdco Management, LLC, a Delaware limited liability company ("Holdco Management"), manages Sixth Street Specialty Lending Advisers Holdings, LLC, a Delaware limited liability company ("Adviser Holdings"). The business and affairs of Sixth Street Specialty Lending Advisers, LLC, a Delaware limited liability company ("Adviser"), are managed by Adviser Holdings, the sole member of Adviser. Sixth Street Specialty Lending, Inc. is managed by Adviser. F7: Sub-Fund HoldCo is managed by its sole member, whose managing member is Alan Waxman ("Mr. Waxman"). Holdco Management is managed by a board of directors, which is currently comprised of Mr. Waxman. Mr. Waxman is the CEO of Holdco Management. Each Reporting Person disclaims beneficial ownership over the reported securities herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of its or his pecuniary interest therein. Row 5 · 2025-06-20 · Conversion · Acquired 531,746 · Balance 1,010,525 F2: Each share of Series D Preferred Stock of the Issuer was convertible at the option of the holder into 0.25 shares of Common Stock of the Issuer and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's IPO. The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO. The Series D Preferred Stock had no expiration date. F6: TSSP Holdco Management, LLC, a Delaware limited liability company ("Holdco Management"), manages Sixth Street Specialty Lending Advisers Holdings, LLC, a Delaware limited liability company ("Adviser Holdings"). The business and affairs of Sixth Street Specialty Lending Advisers, LLC, a Delaware limited liability company ("Adviser"), are managed by Adviser Holdings, the sole member of Adviser. Sixth Street Specialty Lending, Inc. is managed by Adviser. F7: Sub-Fund HoldCo is managed by its sole member, whose managing member is Alan Waxman ("Mr. Waxman"). Holdco Management is managed by a board of directors, which is currently comprised of Mr. Waxman. Mr. Waxman is the CEO of Holdco Management. Each Reporting Person disclaims beneficial ownership over the reported securities herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of its or his pecuniary interest therein. Row 8 · 2025-06-20 · Other · Acquired 118,687 · Balance 1,129,212 F3: The 2018 warrants were exercisable at the option of the holder into shares of Series C Preferred Stock of the Issuer at an exercise price of $1.61 per share and into Common Stock at an exercise price of $6.44 per share. Immediately prior to and in connection with the closing of the Issuer's IPO, the 2018 warrants were exercised on a cashless basis into shares of Series C Preferred Stock which then automatically converted into Common Stock. The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO. F6: TSSP Holdco Management, LLC, a Delaware limited liability company ("Holdco Management"), manages Sixth Street Specialty Lending Advisers Holdings, LLC, a Delaware limited liability company ("Adviser Holdings"). The business and affairs of Sixth Street Specialty Lending Advisers, LLC, a Delaware limited liability company ("Adviser"), are managed by Adviser Holdings, the sole member of Adviser. Sixth Street Specialty Lending, Inc. is managed by Adviser. F7: Sub-Fund HoldCo is managed by its sole member, whose managing member is Alan Waxman ("Mr. Waxman"). Holdco Management is managed by a board of directors, which is currently comprised of Mr. Waxman. Mr. Waxman is the CEO of Holdco Management. Each Reporting Person disclaims beneficial ownership over the reported securities herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of its or his pecuniary interest therein. Row 10 · 2025-06-20 · Other · Acquired 90,059 · Balance 1,219,271 F4: The 2020 warrants were exercisable into Series C preferred stock at a price of $1.93 per share and into Common Stock at a price of $7.73 per share. Immediately prior to and in connection with the closing of the Issuer's IPO the 2020 warrants were exercised on a cashless basis into shares of Series C Preferred Stock which then automatically converted into Common Stock. The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO. F6: TSSP Holdco Management, LLC, a Delaware limited liability company ("Holdco Management"), manages Sixth Street Specialty Lending Advisers Holdings, LLC, a Delaware limited liability company ("Adviser Holdings"). The business and affairs of Sixth Street Specialty Lending Advisers, LLC, a Delaware limited liability company ("Adviser"), are managed by Adviser Holdings, the sole member of Adviser. Sixth Street Specialty Lending, Inc. is managed by Adviser. F7: Sub-Fund HoldCo is managed by its sole member, whose managing member is Alan Waxman ("Mr. Waxman"). Holdco Management is managed by a board of directors, which is currently comprised of Mr. Waxman. Mr. Waxman is the CEO of Holdco Management. Each Reporting Person disclaims beneficial ownership over the reported securities herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of its or his pecuniary interest therein.
Common StockSEC Table I · non-derivative	IndirectHeld by Barnett Equity Holdings II, LLC	10,103,175	Reported balance After 2025-06-20 transaction · row 6 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 6 · 2025-06-20 · Conversion · Acquired 10,103,175 · Balance 10,103,175 F2: Each share of Series D Preferred Stock of the Issuer was convertible at the option of the holder into 0.25 shares of Common Stock of the Issuer and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's IPO. The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO. The Series D Preferred Stock had no expiration date. F5: TSSP Sub-Fund Holdco, LLC, a Delaware limited liability company ("Sub-Fund HoldCo"), is the sole member of each of TAO SPV GP, LLC, a Delaware limited liability company ("TAO SPV"), and Empire SPV GP, LLC, a Delaware limited liability company ("Empire SPV"). TAO SPV is the managing member of each of (i) Barnett Equity Holdings, LLC; (ii) Barnett Equity Holdings II LLC; and (iii) TAO Barnett Investments LLC. Empire SPV is the managing member of TOP III Barnett Investments, LLC. F7: Sub-Fund HoldCo is managed by its sole member, whose managing member is Alan Waxman ("Mr. Waxman"). Holdco Management is managed by a board of directors, which is currently comprised of Mr. Waxman. Mr. Waxman is the CEO of Holdco Management. Each Reporting Person disclaims beneficial ownership over the reported securities herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of its or his pecuniary interest therein.
Series C Preferred StockSEC Table II · derivative / convertible security	IndirectHeld by Barnett Equity Holdings, LLC	0	Reported balance After 2025-06-20 transaction · row 11 Instrument identity requires review; Table II rows are not merged. 1 source row Row 11 · 2025-06-20 · Conversion · Disposed 6,884,058 · Balance 0 F1: Each share of Series C Preferred Stock of Caris Life Sciences, Inc. (the "Issuer") was convertible at the option of the holder into 0.25 shares of common stock $.001 par value of the Issuer (the "Common Stock") and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's initial public offering (the "IPO"). The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's amended and restated certificate of formation (the "Charter"), in connection with the IPO. The Series C Preferred Stock had no expiration date. F5: TSSP Sub-Fund Holdco, LLC, a Delaware limited liability company ("Sub-Fund HoldCo"), is the sole member of each of TAO SPV GP, LLC, a Delaware limited liability company ("TAO SPV"), and Empire SPV GP, LLC, a Delaware limited liability company ("Empire SPV"). TAO SPV is the managing member of each of (i) Barnett Equity Holdings, LLC; (ii) Barnett Equity Holdings II LLC; and (iii) TAO Barnett Investments LLC. Empire SPV is the managing member of TOP III Barnett Investments, LLC. F7: Sub-Fund HoldCo is managed by its sole member, whose managing member is Alan Waxman ("Mr. Waxman"). Holdco Management is managed by a board of directors, which is currently comprised of Mr. Waxman. Mr. Waxman is the CEO of Holdco Management. Each Reporting Person disclaims beneficial ownership over the reported securities herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of its or his pecuniary interest therein.
Series C Preferred StockSEC Table II · derivative / convertible security	IndirectHeld by TOP III Barnett Investments, LLC	0	Reported balance After 2025-06-20 transaction · row 12 Instrument identity requires review; Table II rows are not merged. 1 source row Row 12 · 2025-06-20 · Conversion · Disposed 15,527,951 · Balance 0 F1: Each share of Series C Preferred Stock of Caris Life Sciences, Inc. (the "Issuer") was convertible at the option of the holder into 0.25 shares of common stock $.001 par value of the Issuer (the "Common Stock") and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's initial public offering (the "IPO"). The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's amended and restated certificate of formation (the "Charter"), in connection with the IPO. The Series C Preferred Stock had no expiration date. F5: TSSP Sub-Fund Holdco, LLC, a Delaware limited liability company ("Sub-Fund HoldCo"), is the sole member of each of TAO SPV GP, LLC, a Delaware limited liability company ("TAO SPV"), and Empire SPV GP, LLC, a Delaware limited liability company ("Empire SPV"). TAO SPV is the managing member of each of (i) Barnett Equity Holdings, LLC; (ii) Barnett Equity Holdings II LLC; and (iii) TAO Barnett Investments LLC. Empire SPV is the managing member of TOP III Barnett Investments, LLC. F7: Sub-Fund HoldCo is managed by its sole member, whose managing member is Alan Waxman ("Mr. Waxman"). Holdco Management is managed by a board of directors, which is currently comprised of Mr. Waxman. Mr. Waxman is the CEO of Holdco Management. Each Reporting Person disclaims beneficial ownership over the reported securities herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of its or his pecuniary interest therein.
Series C Preferred StockSEC Table II · derivative / convertible security	IndirectHeld by TAO Barnett Investments LLC	0	Reported balance After 2025-06-20 transaction · row 13 Instrument identity requires review; Table II rows are not merged. 1 source row Row 13 · 2025-06-20 · Conversion · Disposed 13,975,155 · Balance 0 F1: Each share of Series C Preferred Stock of Caris Life Sciences, Inc. (the "Issuer") was convertible at the option of the holder into 0.25 shares of common stock $.001 par value of the Issuer (the "Common Stock") and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's initial public offering (the "IPO"). The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's amended and restated certificate of formation (the "Charter"), in connection with the IPO. The Series C Preferred Stock had no expiration date. F5: TSSP Sub-Fund Holdco, LLC, a Delaware limited liability company ("Sub-Fund HoldCo"), is the sole member of each of TAO SPV GP, LLC, a Delaware limited liability company ("TAO SPV"), and Empire SPV GP, LLC, a Delaware limited liability company ("Empire SPV"). TAO SPV is the managing member of each of (i) Barnett Equity Holdings, LLC; (ii) Barnett Equity Holdings II LLC; and (iii) TAO Barnett Investments LLC. Empire SPV is the managing member of TOP III Barnett Investments, LLC. F7: Sub-Fund HoldCo is managed by its sole member, whose managing member is Alan Waxman ("Mr. Waxman"). Holdco Management is managed by a board of directors, which is currently comprised of Mr. Waxman. Mr. Waxman is the CEO of Holdco Management. Each Reporting Person disclaims beneficial ownership over the reported securities herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of its or his pecuniary interest therein.
Series C Preferred StockSEC Table II · derivative / convertible security	IndirectHeld by Sixth Street Specialty Lending, Inc.	0	Reported balance After 2025-06-20 transaction · row 14 Instrument identity requires review; Table II rows are not merged. 1 source row Row 14 · 2025-06-20 · Conversion · Disposed 1,915,114 · Balance 0 F1: Each share of Series C Preferred Stock of Caris Life Sciences, Inc. (the "Issuer") was convertible at the option of the holder into 0.25 shares of common stock $.001 par value of the Issuer (the "Common Stock") and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's initial public offering (the "IPO"). The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's amended and restated certificate of formation (the "Charter"), in connection with the IPO. The Series C Preferred Stock had no expiration date. F6: TSSP Holdco Management, LLC, a Delaware limited liability company ("Holdco Management"), manages Sixth Street Specialty Lending Advisers Holdings, LLC, a Delaware limited liability company ("Adviser Holdings"). The business and affairs of Sixth Street Specialty Lending Advisers, LLC, a Delaware limited liability company ("Adviser"), are managed by Adviser Holdings, the sole member of Adviser. Sixth Street Specialty Lending, Inc. is managed by Adviser. F7: Sub-Fund HoldCo is managed by its sole member, whose managing member is Alan Waxman ("Mr. Waxman"). Holdco Management is managed by a board of directors, which is currently comprised of Mr. Waxman. Mr. Waxman is the CEO of Holdco Management. Each Reporting Person disclaims beneficial ownership over the reported securities herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of its or his pecuniary interest therein.
Series D Preferred StockSEC Table II · derivative / convertible security	IndirectHeld by Sixth Street Specialty Lending, Inc.	0	Reported balance After 2025-06-20 transaction · row 15 Instrument identity requires review; Table II rows are not merged. 1 source row Row 15 · 2025-06-20 · Conversion · Disposed 1,240,740 · Balance 0 F2: Each share of Series D Preferred Stock of the Issuer was convertible at the option of the holder into 0.25 shares of Common Stock of the Issuer and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's IPO. The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO. The Series D Preferred Stock had no expiration date. F6: TSSP Holdco Management, LLC, a Delaware limited liability company ("Holdco Management"), manages Sixth Street Specialty Lending Advisers Holdings, LLC, a Delaware limited liability company ("Adviser Holdings"). The business and affairs of Sixth Street Specialty Lending Advisers, LLC, a Delaware limited liability company ("Adviser"), are managed by Adviser Holdings, the sole member of Adviser. Sixth Street Specialty Lending, Inc. is managed by Adviser. F7: Sub-Fund HoldCo is managed by its sole member, whose managing member is Alan Waxman ("Mr. Waxman"). Holdco Management is managed by a board of directors, which is currently comprised of Mr. Waxman. Mr. Waxman is the CEO of Holdco Management. Each Reporting Person disclaims beneficial ownership over the reported securities herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of its or his pecuniary interest therein.
Series D Preferred StockSEC Table II · derivative / convertible security	IndirectHeld by Barnett Equity Holdings II, LLC	0	Reported balance After 2025-06-20 transaction · row 16 Instrument identity requires review; Table II rows are not merged. 1 source row Row 16 · 2025-06-20 · Conversion · Disposed 23,574,073 · Balance 0 F2: Each share of Series D Preferred Stock of the Issuer was convertible at the option of the holder into 0.25 shares of Common Stock of the Issuer and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's IPO. The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO. The Series D Preferred Stock had no expiration date. F5: TSSP Sub-Fund Holdco, LLC, a Delaware limited liability company ("Sub-Fund HoldCo"), is the sole member of each of TAO SPV GP, LLC, a Delaware limited liability company ("TAO SPV"), and Empire SPV GP, LLC, a Delaware limited liability company ("Empire SPV"). TAO SPV is the managing member of each of (i) Barnett Equity Holdings, LLC; (ii) Barnett Equity Holdings II LLC; and (iii) TAO Barnett Investments LLC. Empire SPV is the managing member of TOP III Barnett Investments, LLC. F7: Sub-Fund HoldCo is managed by its sole member, whose managing member is Alan Waxman ("Mr. Waxman"). Holdco Management is managed by a board of directors, which is currently comprised of Mr. Waxman. Mr. Waxman is the CEO of Holdco Management. Each Reporting Person disclaims beneficial ownership over the reported securities herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of its or his pecuniary interest therein.
2018 WarrantsSEC Table II · derivative / convertible security · Expires 2025-09-20	IndirectHeld by Barnett Equity Holdings, LLC	0	Reported balance After 2025-06-20 transaction · row 17 Instrument identity requires review; Table II rows are not merged. 1 source row Row 17 · 2025-06-20 · Other · Disposed 13,009,892 · Balance 0 F3: The 2018 warrants were exercisable at the option of the holder into shares of Series C Preferred Stock of the Issuer at an exercise price of $1.61 per share and into Common Stock at an exercise price of $6.44 per share. Immediately prior to and in connection with the closing of the Issuer's IPO, the 2018 warrants were exercised on a cashless basis into shares of Series C Preferred Stock which then automatically converted into Common Stock. The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO. F5: TSSP Sub-Fund Holdco, LLC, a Delaware limited liability company ("Sub-Fund HoldCo"), is the sole member of each of TAO SPV GP, LLC, a Delaware limited liability company ("TAO SPV"), and Empire SPV GP, LLC, a Delaware limited liability company ("Empire SPV"). TAO SPV is the managing member of each of (i) Barnett Equity Holdings, LLC; (ii) Barnett Equity Holdings II LLC; and (iii) TAO Barnett Investments LLC. Empire SPV is the managing member of TOP III Barnett Investments, LLC. F7: Sub-Fund HoldCo is managed by its sole member, whose managing member is Alan Waxman ("Mr. Waxman"). Holdco Management is managed by a board of directors, which is currently comprised of Mr. Waxman. Mr. Waxman is the CEO of Holdco Management. Each Reporting Person disclaims beneficial ownership over the reported securities herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of its or his pecuniary interest therein.
2018 WarrantsSEC Table II · derivative / convertible security · Expires 2025-09-20	IndirectHeld by Sixth Street Specialty Lending, Inc.	0	Reported balance After 2025-06-20 transaction · row 18 Instrument identity requires review; Table II rows are not merged. 1 source row Row 18 · 2025-06-20 · Other · Disposed 684,731 · Balance 0 F3: The 2018 warrants were exercisable at the option of the holder into shares of Series C Preferred Stock of the Issuer at an exercise price of $1.61 per share and into Common Stock at an exercise price of $6.44 per share. Immediately prior to and in connection with the closing of the Issuer's IPO, the 2018 warrants were exercised on a cashless basis into shares of Series C Preferred Stock which then automatically converted into Common Stock. The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO. F6: TSSP Holdco Management, LLC, a Delaware limited liability company ("Holdco Management"), manages Sixth Street Specialty Lending Advisers Holdings, LLC, a Delaware limited liability company ("Adviser Holdings"). The business and affairs of Sixth Street Specialty Lending Advisers, LLC, a Delaware limited liability company ("Adviser"), are managed by Adviser Holdings, the sole member of Adviser. Sixth Street Specialty Lending, Inc. is managed by Adviser. F7: Sub-Fund HoldCo is managed by its sole member, whose managing member is Alan Waxman ("Mr. Waxman"). Holdco Management is managed by a board of directors, which is currently comprised of Mr. Waxman. Mr. Waxman is the CEO of Holdco Management. Each Reporting Person disclaims beneficial ownership over the reported securities herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of its or his pecuniary interest therein.
2020 WarrantsSEC Table II · derivative / convertible security · Expires 2027-04-02	IndirectHeld by Barnett Equity Holdings, LLC	0	Reported balance After 2025-06-20 transaction · row 19 Instrument identity requires review; Table II rows are not merged. 1 source row Row 19 · 2025-06-20 · Other · Disposed 10,829,823 · Balance 0 F4: The 2020 warrants were exercisable into Series C preferred stock at a price of $1.93 per share and into Common Stock at a price of $7.73 per share. Immediately prior to and in connection with the closing of the Issuer's IPO the 2020 warrants were exercised on a cashless basis into shares of Series C Preferred Stock which then automatically converted into Common Stock. The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO. F5: TSSP Sub-Fund Holdco, LLC, a Delaware limited liability company ("Sub-Fund HoldCo"), is the sole member of each of TAO SPV GP, LLC, a Delaware limited liability company ("TAO SPV"), and Empire SPV GP, LLC, a Delaware limited liability company ("Empire SPV"). TAO SPV is the managing member of each of (i) Barnett Equity Holdings, LLC; (ii) Barnett Equity Holdings II LLC; and (iii) TAO Barnett Investments LLC. Empire SPV is the managing member of TOP III Barnett Investments, LLC. F7: Sub-Fund HoldCo is managed by its sole member, whose managing member is Alan Waxman ("Mr. Waxman"). Holdco Management is managed by a board of directors, which is currently comprised of Mr. Waxman. Mr. Waxman is the CEO of Holdco Management. Each Reporting Person disclaims beneficial ownership over the reported securities herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of its or his pecuniary interest therein.
2020 WarrantsSEC Table II · derivative / convertible security · Expires 2027-04-02	IndirectHeld by Sixth Street Specialty Lending, Inc.	0	Reported balance After 2025-06-20 transaction · row 20 Instrument identity requires review; Table II rows are not merged. 1 source row Row 20 · 2025-06-20 · Other · Disposed 569,991 · Balance 0 F4: The 2020 warrants were exercisable into Series C preferred stock at a price of $1.93 per share and into Common Stock at a price of $7.73 per share. Immediately prior to and in connection with the closing of the Issuer's IPO the 2020 warrants were exercised on a cashless basis into shares of Series C Preferred Stock which then automatically converted into Common Stock. The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO. F6: TSSP Holdco Management, LLC, a Delaware limited liability company ("Holdco Management"), manages Sixth Street Specialty Lending Advisers Holdings, LLC, a Delaware limited liability company ("Adviser Holdings"). The business and affairs of Sixth Street Specialty Lending Advisers, LLC, a Delaware limited liability company ("Adviser"), are managed by Adviser Holdings, the sole member of Adviser. Sixth Street Specialty Lending, Inc. is managed by Adviser. F7: Sub-Fund HoldCo is managed by its sole member, whose managing member is Alan Waxman ("Mr. Waxman"). Holdco Management is managed by a board of directors, which is currently comprised of Mr. Waxman. Mr. Waxman is the CEO of Holdco Management. Each Reporting Person disclaims beneficial ownership over the reported securities herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of its or his pecuniary interest therein.

Filing footnotes · ownership attribution and instrument terms

F1: Each share of Series C Preferred Stock of Caris Life Sciences, Inc. (the "Issuer") was convertible at the option of the holder into 0.25 shares of common stock $.001 par value of the Issuer (the "Common Stock") and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's initial public offering (the "IPO"). The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's amended and restated certificate of formation (the "Charter"), in connection with the IPO. The Series C Preferred Stock had no expiration date.

F2: Each share of Series D Preferred Stock of the Issuer was convertible at the option of the holder into 0.25 shares of Common Stock of the Issuer and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's IPO. The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO. The Series D Preferred Stock had no expiration date.

F3: The 2018 warrants were exercisable at the option of the holder into shares of Series C Preferred Stock of the Issuer at an exercise price of $1.61 per share and into Common Stock at an exercise price of $6.44 per share. Immediately prior to and in connection with the closing of the Issuer's IPO, the 2018 warrants were exercised on a cashless basis into shares of Series C Preferred Stock which then automatically converted into Common Stock. The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO.

F4: The 2020 warrants were exercisable into Series C preferred stock at a price of $1.93 per share and into Common Stock at a price of $7.73 per share. Immediately prior to and in connection with the closing of the Issuer's IPO the 2020 warrants were exercised on a cashless basis into shares of Series C Preferred Stock which then automatically converted into Common Stock. The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO.

F5: TSSP Sub-Fund Holdco, LLC, a Delaware limited liability company ("Sub-Fund HoldCo"), is the sole member of each of TAO SPV GP, LLC, a Delaware limited liability company ("TAO SPV"), and Empire SPV GP, LLC, a Delaware limited liability company ("Empire SPV"). TAO SPV is the managing member of each of (i) Barnett Equity Holdings, LLC; (ii) Barnett Equity Holdings II LLC; and (iii) TAO Barnett Investments LLC. Empire SPV is the managing member of TOP III Barnett Investments, LLC.

F6: TSSP Holdco Management, LLC, a Delaware limited liability company ("Holdco Management"), manages Sixth Street Specialty Lending Advisers Holdings, LLC, a Delaware limited liability company ("Adviser Holdings"). The business and affairs of Sixth Street Specialty Lending Advisers, LLC, a Delaware limited liability company ("Adviser"), are managed by Adviser Holdings, the sole member of Adviser. Sixth Street Specialty Lending, Inc. is managed by Adviser.

F7: Sub-Fund HoldCo is managed by its sole member, whose managing member is Alan Waxman ("Mr. Waxman"). Holdco Management is managed by a board of directors, which is currently comprised of Mr. Waxman. Mr. Waxman is the CEO of Holdco Management. Each Reporting Person disclaims beneficial ownership over the reported securities herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of its or his pecuniary interest therein.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
September 01, 2026 Filed Sep 3, 2026 20:30 UTC	Sixth Street Lending Partners NONE · Entity 1805	PurchaseCommon shares of beneficial interest, par value $0.001	255,924	$28.78	$7,365,492.72	Disclosure SEC source: 0001193125-26-381963 · ownership.xml · nonDerivative · entry 2 Waxman Alan · CIK 0001515132 · Vice President 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 2,255,597 F2 · ownership.nature: Shares are held directly by Sixth Street Lending Partners Advisers, LLC ("Adviser"). Adviser is managed by TSSP HoldCo Management, LLC ("Holdco Management"). Holdco Management is managed by a board of directors, which is currently comprised of Reporting Person. Reporting Person is the CEO of Holdco Management. Read SEC document
September 01, 2026 Filed Sep 3, 2026 20:30 UTC	Sixth Street Lending Partners NONE · Entity 1805	PurchaseCommon shares of beneficial interest, par value $0.001	1,405,583	$28.78	$40,452,678.74	Disclosure SEC source: 0001193125-26-381963 · ownership.xml · nonDerivative · entry 1 Waxman Alan · CIK 0001515132 · Vice President 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 12,560,764 F1 · ownership.nature: Shares held directly by Sixth Street Lending Partners Note Issuer, LLC ("Note Issuer"). Note Issuer is controlled by its members, which are indirectly controlled by TAO Sutton Holdings, LLC. TAO Insurance Holdings, LLC is the managing member of TAO Sutton Holdings, LLC. A. Michael Muscolino is the managing member of TAO Insurance Holdings, LLC. Pursuant to the limited liability company agreement of TAO Insurance Holdings, LLC, Reporting Person, as designated member of TAO Insurance Holdings, LLC has the authority to appoint the managing member of TAO Insurance Holdings, LLC. Read SEC document
June 23, 2026 Filed Jun 25, 2026 20:05 UTC	Sixth Street Lending Partners NONE · Entity 1805	PurchaseCommon shares of beneficial interest, par value $0.001	124,477	$28.81	$3,586,182.37	Disclosure SEC source: 0001193125-26-282741 · ownership.xml · nonDerivative · entry 2 Waxman Alan · CIK 0001515132 · Vice President 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 1,999,673 F2 · ownership.nature: Shares are held directly by Sixth Street Lending Partners Advisers, LLC ("Adviser"). Adviser is managed by TSSP HoldCo Management, LLC ("Holdco Management"). Holdco Management is managed by a board of directors, which is currently comprised of Reporting Person. Reporting Person is the CEO of Holdco Management. Read SEC document
June 23, 2026 Filed Jun 25, 2026 20:05 UTC	Sixth Street Lending Partners NONE · Entity 1805	PurchaseCommon shares of beneficial interest, par value $0.001	683,654	$28.81	$19,696,071.74	Disclosure SEC source: 0001193125-26-282741 · ownership.xml · nonDerivative · entry 1 Waxman Alan · CIK 0001515132 · Vice President 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 11,155,181 F1 · ownership.nature: Shares held directly by Sixth Street Lending Partners Note Issuer, LLC ("Note Issuer"). Note Issuer is controlled by its members, which are indirectly controlled by TAO Sutton Holdings, LLC. TAO Insurance Holdings, LLC is the managing member of TAO Sutton Holdings, LLC. A. Michael Muscolino is the managing member of TAO Insurance Holdings, LLC. Pursuant to the limited liability company agreement of TAO Insurance Holdings, LLC, Alan Waxman, as designated member of TAO Insurance Holdings, LLC has the authority to appoint the managing member of TAO Insurance Holdings, LLC. Read SEC document
March 10, 2026 Filed Mar 11, 2026 20:20 UTC	Sixth Street Specialty Lending, Inc. TSLX · Entity 4591	PurchaseCommon Stock	45,000	$18.47	$831,150.00	Disclosure SEC source: 0001193125-26-102222 · ownership.xml · nonDerivative · entry 2 Waxman Alan · CIK 0001515132 · Vice President 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 545,000 F2 · price: The price reported in Column 4 is a weighted average price. These Shares were purchased in multiple transactions at prices ranging from $18.27 to $18.57, inclusive. Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price within the range set forth above. Read SEC document
March 09, 2026 Filed Mar 11, 2026 20:20 UTC	Sixth Street Specialty Lending, Inc. TSLX · Entity 4591	PurchaseCommon Stock	200,000	$18.18	$3,636,000.00	Disclosure SEC source: 0001193125-26-102222 · ownership.xml · nonDerivative · entry 1 Waxman Alan · CIK 0001515132 · Vice President 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 500,000 F1 · price: The price reported in Column 4 is a weighted average price. These shares of common stock, par value $0.01 per share (the "Shares") were purchased in multiple transactions at prices ranging from $17.865 to $18.445, inclusive. Mr. Waxman ("Reporting Person") undertakes to provide to Sixth Street Specialty Lending, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price within the range set forth above. Read SEC document
March 06, 2026 Filed Mar 9, 2026 20:19 UTC	Sixth Street Specialty Lending, Inc. TSLX · Entity 4591	PurchaseCommon Stock	200,000	$18.42	$3,684,000.00	Disclosure SEC source: 0001193125-26-098557 · ownership.xml · nonDerivative · entry 2 Waxman Alan · CIK 0001515132 · Vice President 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 300,000 F2 · price: The price reported in Column 4 is a weighted average price. These Shares were purchased in multiple transactions at prices ranging from $18.28 to $18.635, inclusive. Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price within the range set forth above. Read SEC document
March 05, 2026 Filed Mar 9, 2026 20:19 UTC	Sixth Street Specialty Lending, Inc. TSLX · Entity 4591	PurchaseCommon Stock	100,000	$18.46	$1,846,000.00	Disclosure SEC source: 0001193125-26-098557 · ownership.xml · nonDerivative · entry 1 Waxman Alan · CIK 0001515132 · Vice President 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 100,000 F1 · price: The price reported in Column 4 is a weighted average price. These shares of common stock, par value $0.01 per share (the "Shares") were purchased in multiple transactions at prices ranging from $18.38 to $18.525, inclusive. Mr. Waxman ("Reporting Person") undertakes to provide to Sixth Street Specialty Lending, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price within the range set forth above. Read SEC document
June 20, 2025 Filed Jun 23, 2025 20:45 UTC	Caris Life Sciences, Inc. CAI · Entity 3706	Other2020 Warrants · Derivative	569,991	$0.00	$0.00	Disclosure SEC source: 0000950170-25-089040 · ownership.xml · derivative · entry 20 TSSP Sub-Fund HoldCo LLC · CIK 0001677508 · Former 10% Owner Waxman Alan · CIK 0001515132 · Former 10% Owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Held by Sixth Street Specialty Lending, Inc. Disclosed balance after: 0 Underlying: Common Stock · 90,059 shares Expires 2027-04-02 F4 · derivative.exercise_price: The 2020 warrants were exercisable into Series C preferred stock at a price of $1.93 per share and into Common Stock at a price of $7.73 per share. Immediately prior to and in connection with the closing of the Issuer's IPO the 2020 warrants were exercised on a cashless basis into shares of Series C Preferred Stock which then automatically converted into Common Stock. The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO. F4 · kind: The 2020 warrants were exercisable into Series C preferred stock at a price of $1.93 per share and into Common Stock at a price of $7.73 per share. Immediately prior to and in connection with the closing of the Issuer's IPO the 2020 warrants were exercised on a cashless basis into shares of Series C Preferred Stock which then automatically converted into Common Stock. The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO. F4 · derivative.exercise_date: The 2020 warrants were exercisable into Series C preferred stock at a price of $1.93 per share and into Common Stock at a price of $7.73 per share. Immediately prior to and in connection with the closing of the Issuer's IPO the 2020 warrants were exercised on a cashless basis into shares of Series C Preferred Stock which then automatically converted into Common Stock. The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO. F4 · derivative.underlying_shares: The 2020 warrants were exercisable into Series C preferred stock at a price of $1.93 per share and into Common Stock at a price of $7.73 per share. Immediately prior to and in connection with the closing of the Issuer's IPO the 2020 warrants were exercised on a cashless basis into shares of Series C Preferred Stock which then automatically converted into Common Stock. The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO. F6 · ownership.nature: TSSP Holdco Management, LLC, a Delaware limited liability company ("Holdco Management"), manages Sixth Street Specialty Lending Advisers Holdings, LLC, a Delaware limited liability company ("Adviser Holdings"). The business and affairs of Sixth Street Specialty Lending Advisers, LLC, a Delaware limited liability company ("Adviser"), are managed by Adviser Holdings, the sole member of Adviser. Sixth Street Specialty Lending, Inc. is managed by Adviser. F7 · ownership.nature: Sub-Fund HoldCo is managed by its sole member, whose managing member is Alan Waxman ("Mr. Waxman"). Holdco Management is managed by a board of directors, which is currently comprised of Mr. Waxman. Mr. Waxman is the CEO of Holdco Management. Each Reporting Person disclaims beneficial ownership over the reported securities herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of its or his pecuniary interest therein. Read SEC document
June 20, 2025 Filed Jun 23, 2025 20:45 UTC	Caris Life Sciences, Inc. CAI · Entity 3706	Other2020 Warrants · Derivative	10,829,823	$0.00	$0.00	Disclosure SEC source: 0000950170-25-089040 · ownership.xml · derivative · entry 19 TSSP Sub-Fund HoldCo LLC · CIK 0001677508 · Former 10% Owner Waxman Alan · CIK 0001515132 · Former 10% Owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Held by Barnett Equity Holdings, LLC Disclosed balance after: 0 Underlying: Common Stock · 1,711,113 shares Expires 2027-04-02 F4 · derivative.exercise_price: The 2020 warrants were exercisable into Series C preferred stock at a price of $1.93 per share and into Common Stock at a price of $7.73 per share. Immediately prior to and in connection with the closing of the Issuer's IPO the 2020 warrants were exercised on a cashless basis into shares of Series C Preferred Stock which then automatically converted into Common Stock. The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO. F4 · kind: The 2020 warrants were exercisable into Series C preferred stock at a price of $1.93 per share and into Common Stock at a price of $7.73 per share. Immediately prior to and in connection with the closing of the Issuer's IPO the 2020 warrants were exercised on a cashless basis into shares of Series C Preferred Stock which then automatically converted into Common Stock. The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO. F4 · derivative.exercise_date: The 2020 warrants were exercisable into Series C preferred stock at a price of $1.93 per share and into Common Stock at a price of $7.73 per share. Immediately prior to and in connection with the closing of the Issuer's IPO the 2020 warrants were exercised on a cashless basis into shares of Series C Preferred Stock which then automatically converted into Common Stock. The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO. F4 · derivative.underlying_shares: The 2020 warrants were exercisable into Series C preferred stock at a price of $1.93 per share and into Common Stock at a price of $7.73 per share. Immediately prior to and in connection with the closing of the Issuer's IPO the 2020 warrants were exercised on a cashless basis into shares of Series C Preferred Stock which then automatically converted into Common Stock. The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO. F5 · ownership.nature: TSSP Sub-Fund Holdco, LLC, a Delaware limited liability company ("Sub-Fund HoldCo"), is the sole member of each of TAO SPV GP, LLC, a Delaware limited liability company ("TAO SPV"), and Empire SPV GP, LLC, a Delaware limited liability company ("Empire SPV"). TAO SPV is the managing member of each of (i) Barnett Equity Holdings, LLC; (ii) Barnett Equity Holdings II LLC; and (iii) TAO Barnett Investments LLC. Empire SPV is the managing member of TOP III Barnett Investments, LLC. F7 · ownership.nature: Sub-Fund HoldCo is managed by its sole member, whose managing member is Alan Waxman ("Mr. Waxman"). Holdco Management is managed by a board of directors, which is currently comprised of Mr. Waxman. Mr. Waxman is the CEO of Holdco Management. Each Reporting Person disclaims beneficial ownership over the reported securities herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of its or his pecuniary interest therein. Read SEC document
June 20, 2025 Filed Jun 23, 2025 20:45 UTC	Caris Life Sciences, Inc. CAI · Entity 3706	Other2018 Warrants · Derivative	684,731	$0.00	$0.00	Disclosure SEC source: 0000950170-25-089040 · ownership.xml · derivative · entry 18 TSSP Sub-Fund HoldCo LLC · CIK 0001677508 · Former 10% Owner Waxman Alan · CIK 0001515132 · Former 10% Owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Held by Sixth Street Specialty Lending, Inc. Disclosed balance after: 0 Underlying: Common Stock · 118,687 shares Expires 2025-09-20 F3 · derivative.exercise_price: The 2018 warrants were exercisable at the option of the holder into shares of Series C Preferred Stock of the Issuer at an exercise price of $1.61 per share and into Common Stock at an exercise price of $6.44 per share. Immediately prior to and in connection with the closing of the Issuer's IPO, the 2018 warrants were exercised on a cashless basis into shares of Series C Preferred Stock which then automatically converted into Common Stock. The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO. F3 · kind: The 2018 warrants were exercisable at the option of the holder into shares of Series C Preferred Stock of the Issuer at an exercise price of $1.61 per share and into Common Stock at an exercise price of $6.44 per share. Immediately prior to and in connection with the closing of the Issuer's IPO, the 2018 warrants were exercised on a cashless basis into shares of Series C Preferred Stock which then automatically converted into Common Stock. The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO. F3 · derivative.exercise_date: The 2018 warrants were exercisable at the option of the holder into shares of Series C Preferred Stock of the Issuer at an exercise price of $1.61 per share and into Common Stock at an exercise price of $6.44 per share. Immediately prior to and in connection with the closing of the Issuer's IPO, the 2018 warrants were exercised on a cashless basis into shares of Series C Preferred Stock which then automatically converted into Common Stock. The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO. F3 · derivative.underlying_shares: The 2018 warrants were exercisable at the option of the holder into shares of Series C Preferred Stock of the Issuer at an exercise price of $1.61 per share and into Common Stock at an exercise price of $6.44 per share. Immediately prior to and in connection with the closing of the Issuer's IPO, the 2018 warrants were exercised on a cashless basis into shares of Series C Preferred Stock which then automatically converted into Common Stock. The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO. F6 · ownership.nature: TSSP Holdco Management, LLC, a Delaware limited liability company ("Holdco Management"), manages Sixth Street Specialty Lending Advisers Holdings, LLC, a Delaware limited liability company ("Adviser Holdings"). The business and affairs of Sixth Street Specialty Lending Advisers, LLC, a Delaware limited liability company ("Adviser"), are managed by Adviser Holdings, the sole member of Adviser. Sixth Street Specialty Lending, Inc. is managed by Adviser. F7 · ownership.nature: Sub-Fund HoldCo is managed by its sole member, whose managing member is Alan Waxman ("Mr. Waxman"). Holdco Management is managed by a board of directors, which is currently comprised of Mr. Waxman. Mr. Waxman is the CEO of Holdco Management. Each Reporting Person disclaims beneficial ownership over the reported securities herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of its or his pecuniary interest therein. Read SEC document
June 20, 2025 Filed Jun 23, 2025 20:45 UTC	Caris Life Sciences, Inc. CAI · Entity 3706	Other2018 Warrants · Derivative	13,009,892	$0.00	$0.00	Disclosure SEC source: 0000950170-25-089040 · ownership.xml · derivative · entry 17 TSSP Sub-Fund HoldCo LLC · CIK 0001677508 · Former 10% Owner Waxman Alan · CIK 0001515132 · Former 10% Owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Held by Barnett Equity Holdings, LLC Disclosed balance after: 0 Underlying: Common Stock · 2,255,048 shares Expires 2025-09-20 F3 · derivative.exercise_price: The 2018 warrants were exercisable at the option of the holder into shares of Series C Preferred Stock of the Issuer at an exercise price of $1.61 per share and into Common Stock at an exercise price of $6.44 per share. Immediately prior to and in connection with the closing of the Issuer's IPO, the 2018 warrants were exercised on a cashless basis into shares of Series C Preferred Stock which then automatically converted into Common Stock. The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO. F3 · kind: The 2018 warrants were exercisable at the option of the holder into shares of Series C Preferred Stock of the Issuer at an exercise price of $1.61 per share and into Common Stock at an exercise price of $6.44 per share. Immediately prior to and in connection with the closing of the Issuer's IPO, the 2018 warrants were exercised on a cashless basis into shares of Series C Preferred Stock which then automatically converted into Common Stock. The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO. F3 · derivative.exercise_date: The 2018 warrants were exercisable at the option of the holder into shares of Series C Preferred Stock of the Issuer at an exercise price of $1.61 per share and into Common Stock at an exercise price of $6.44 per share. Immediately prior to and in connection with the closing of the Issuer's IPO, the 2018 warrants were exercised on a cashless basis into shares of Series C Preferred Stock which then automatically converted into Common Stock. The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO. F3 · derivative.underlying_shares: The 2018 warrants were exercisable at the option of the holder into shares of Series C Preferred Stock of the Issuer at an exercise price of $1.61 per share and into Common Stock at an exercise price of $6.44 per share. Immediately prior to and in connection with the closing of the Issuer's IPO, the 2018 warrants were exercised on a cashless basis into shares of Series C Preferred Stock which then automatically converted into Common Stock. The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO. F5 · ownership.nature: TSSP Sub-Fund Holdco, LLC, a Delaware limited liability company ("Sub-Fund HoldCo"), is the sole member of each of TAO SPV GP, LLC, a Delaware limited liability company ("TAO SPV"), and Empire SPV GP, LLC, a Delaware limited liability company ("Empire SPV"). TAO SPV is the managing member of each of (i) Barnett Equity Holdings, LLC; (ii) Barnett Equity Holdings II LLC; and (iii) TAO Barnett Investments LLC. Empire SPV is the managing member of TOP III Barnett Investments, LLC. F7 · ownership.nature: Sub-Fund HoldCo is managed by its sole member, whose managing member is Alan Waxman ("Mr. Waxman"). Holdco Management is managed by a board of directors, which is currently comprised of Mr. Waxman. Mr. Waxman is the CEO of Holdco Management. Each Reporting Person disclaims beneficial ownership over the reported securities herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of its or his pecuniary interest therein. Read SEC document
June 20, 2025 Filed Jun 23, 2025 20:45 UTC	Caris Life Sciences, Inc. CAI · Entity 3706	ConversionSeries D Preferred Stock · Derivative	23,574,073	$0.00	$0.00	Disclosure SEC source: 0000950170-25-089040 · ownership.xml · derivative · entry 16 TSSP Sub-Fund HoldCo LLC · CIK 0001677508 · Former 10% Owner Waxman Alan · CIK 0001515132 · Former 10% Owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Held by Barnett Equity Holdings II, LLC Disclosed balance after: 0 Underlying: Common Stock · 10,103,175 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each share of Series D Preferred Stock of the Issuer was convertible at the option of the holder into 0.25 shares of Common Stock of the Issuer and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's IPO. The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO. The Series D Preferred Stock had no expiration date. F2 · kind: Each share of Series D Preferred Stock of the Issuer was convertible at the option of the holder into 0.25 shares of Common Stock of the Issuer and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's IPO. The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO. The Series D Preferred Stock had no expiration date. F2 · derivative.exercise_date: Each share of Series D Preferred Stock of the Issuer was convertible at the option of the holder into 0.25 shares of Common Stock of the Issuer and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's IPO. The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO. The Series D Preferred Stock had no expiration date. F2 · derivative.expiration_date: Each share of Series D Preferred Stock of the Issuer was convertible at the option of the holder into 0.25 shares of Common Stock of the Issuer and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's IPO. The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO. The Series D Preferred Stock had no expiration date. F2 · derivative.underlying_shares: Each share of Series D Preferred Stock of the Issuer was convertible at the option of the holder into 0.25 shares of Common Stock of the Issuer and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's IPO. The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO. The Series D Preferred Stock had no expiration date. F5 · ownership.nature: TSSP Sub-Fund Holdco, LLC, a Delaware limited liability company ("Sub-Fund HoldCo"), is the sole member of each of TAO SPV GP, LLC, a Delaware limited liability company ("TAO SPV"), and Empire SPV GP, LLC, a Delaware limited liability company ("Empire SPV"). TAO SPV is the managing member of each of (i) Barnett Equity Holdings, LLC; (ii) Barnett Equity Holdings II LLC; and (iii) TAO Barnett Investments LLC. Empire SPV is the managing member of TOP III Barnett Investments, LLC. F7 · ownership.nature: Sub-Fund HoldCo is managed by its sole member, whose managing member is Alan Waxman ("Mr. Waxman"). Holdco Management is managed by a board of directors, which is currently comprised of Mr. Waxman. Mr. Waxman is the CEO of Holdco Management. Each Reporting Person disclaims beneficial ownership over the reported securities herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of its or his pecuniary interest therein. Read SEC document
June 20, 2025 Filed Jun 23, 2025 20:45 UTC	Caris Life Sciences, Inc. CAI · Entity 3706	ConversionSeries D Preferred Stock · Derivative	1,240,740	$0.00	$0.00	Disclosure SEC source: 0000950170-25-089040 · ownership.xml · derivative · entry 15 TSSP Sub-Fund HoldCo LLC · CIK 0001677508 · Former 10% Owner Waxman Alan · CIK 0001515132 · Former 10% Owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Held by Sixth Street Specialty Lending, Inc. Disclosed balance after: 0 Underlying: Common Stock · 531,746 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each share of Series D Preferred Stock of the Issuer was convertible at the option of the holder into 0.25 shares of Common Stock of the Issuer and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's IPO. The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO. The Series D Preferred Stock had no expiration date. F2 · kind: Each share of Series D Preferred Stock of the Issuer was convertible at the option of the holder into 0.25 shares of Common Stock of the Issuer and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's IPO. The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO. The Series D Preferred Stock had no expiration date. F2 · derivative.exercise_date: Each share of Series D Preferred Stock of the Issuer was convertible at the option of the holder into 0.25 shares of Common Stock of the Issuer and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's IPO. The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO. The Series D Preferred Stock had no expiration date. F2 · derivative.expiration_date: Each share of Series D Preferred Stock of the Issuer was convertible at the option of the holder into 0.25 shares of Common Stock of the Issuer and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's IPO. The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO. The Series D Preferred Stock had no expiration date. F2 · derivative.underlying_shares: Each share of Series D Preferred Stock of the Issuer was convertible at the option of the holder into 0.25 shares of Common Stock of the Issuer and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's IPO. The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO. The Series D Preferred Stock had no expiration date. F6 · ownership.nature: TSSP Holdco Management, LLC, a Delaware limited liability company ("Holdco Management"), manages Sixth Street Specialty Lending Advisers Holdings, LLC, a Delaware limited liability company ("Adviser Holdings"). The business and affairs of Sixth Street Specialty Lending Advisers, LLC, a Delaware limited liability company ("Adviser"), are managed by Adviser Holdings, the sole member of Adviser. Sixth Street Specialty Lending, Inc. is managed by Adviser. F7 · ownership.nature: Sub-Fund HoldCo is managed by its sole member, whose managing member is Alan Waxman ("Mr. Waxman"). Holdco Management is managed by a board of directors, which is currently comprised of Mr. Waxman. Mr. Waxman is the CEO of Holdco Management. Each Reporting Person disclaims beneficial ownership over the reported securities herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of its or his pecuniary interest therein. Read SEC document
June 20, 2025 Filed Jun 23, 2025 20:45 UTC	Caris Life Sciences, Inc. CAI · Entity 3706	ConversionSeries C Preferred Stock · Derivative	1,915,114	$0.00	$0.00	Disclosure SEC source: 0000950170-25-089040 · ownership.xml · derivative · entry 14 TSSP Sub-Fund HoldCo LLC · CIK 0001677508 · Former 10% Owner Waxman Alan · CIK 0001515132 · Former 10% Owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Held by Sixth Street Specialty Lending, Inc. Disclosed balance after: 0 Underlying: Common Stock · 478,779 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series C Preferred Stock of Caris Life Sciences, Inc. (the "Issuer") was convertible at the option of the holder into 0.25 shares of common stock $.001 par value of the Issuer (the "Common Stock") and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's initial public offering (the "IPO"). The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's amended and restated certificate of formation (the "Charter"), in connection with the IPO. The Series C Preferred Stock had no expiration date. F1 · kind: Each share of Series C Preferred Stock of Caris Life Sciences, Inc. (the "Issuer") was convertible at the option of the holder into 0.25 shares of common stock $.001 par value of the Issuer (the "Common Stock") and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's initial public offering (the "IPO"). The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's amended and restated certificate of formation (the "Charter"), in connection with the IPO. The Series C Preferred Stock had no expiration date. F1 · derivative.exercise_date: Each share of Series C Preferred Stock of Caris Life Sciences, Inc. (the "Issuer") was convertible at the option of the holder into 0.25 shares of common stock $.001 par value of the Issuer (the "Common Stock") and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's initial public offering (the "IPO"). The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's amended and restated certificate of formation (the "Charter"), in connection with the IPO. The Series C Preferred Stock had no expiration date. F1 · derivative.expiration_date: Each share of Series C Preferred Stock of Caris Life Sciences, Inc. (the "Issuer") was convertible at the option of the holder into 0.25 shares of common stock $.001 par value of the Issuer (the "Common Stock") and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's initial public offering (the "IPO"). The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's amended and restated certificate of formation (the "Charter"), in connection with the IPO. The Series C Preferred Stock had no expiration date. F1 · derivative.underlying_shares: Each share of Series C Preferred Stock of Caris Life Sciences, Inc. (the "Issuer") was convertible at the option of the holder into 0.25 shares of common stock $.001 par value of the Issuer (the "Common Stock") and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's initial public offering (the "IPO"). The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's amended and restated certificate of formation (the "Charter"), in connection with the IPO. The Series C Preferred Stock had no expiration date. F6 · ownership.nature: TSSP Holdco Management, LLC, a Delaware limited liability company ("Holdco Management"), manages Sixth Street Specialty Lending Advisers Holdings, LLC, a Delaware limited liability company ("Adviser Holdings"). The business and affairs of Sixth Street Specialty Lending Advisers, LLC, a Delaware limited liability company ("Adviser"), are managed by Adviser Holdings, the sole member of Adviser. Sixth Street Specialty Lending, Inc. is managed by Adviser. F7 · ownership.nature: Sub-Fund HoldCo is managed by its sole member, whose managing member is Alan Waxman ("Mr. Waxman"). Holdco Management is managed by a board of directors, which is currently comprised of Mr. Waxman. Mr. Waxman is the CEO of Holdco Management. Each Reporting Person disclaims beneficial ownership over the reported securities herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of its or his pecuniary interest therein. Read SEC document
June 20, 2025 Filed Jun 23, 2025 20:45 UTC	Caris Life Sciences, Inc. CAI · Entity 3706	ConversionSeries C Preferred Stock · Derivative	13,975,155	$0.00	$0.00	Disclosure SEC source: 0000950170-25-089040 · ownership.xml · derivative · entry 13 TSSP Sub-Fund HoldCo LLC · CIK 0001677508 · Former 10% Owner Waxman Alan · CIK 0001515132 · Former 10% Owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Held by TAO Barnett Investments LLC Disclosed balance after: 0 Underlying: Common Stock · 3,493,789 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series C Preferred Stock of Caris Life Sciences, Inc. (the "Issuer") was convertible at the option of the holder into 0.25 shares of common stock $.001 par value of the Issuer (the "Common Stock") and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's initial public offering (the "IPO"). The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's amended and restated certificate of formation (the "Charter"), in connection with the IPO. The Series C Preferred Stock had no expiration date. F1 · kind: Each share of Series C Preferred Stock of Caris Life Sciences, Inc. (the "Issuer") was convertible at the option of the holder into 0.25 shares of common stock $.001 par value of the Issuer (the "Common Stock") and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's initial public offering (the "IPO"). The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's amended and restated certificate of formation (the "Charter"), in connection with the IPO. The Series C Preferred Stock had no expiration date. F1 · derivative.exercise_date: Each share of Series C Preferred Stock of Caris Life Sciences, Inc. (the "Issuer") was convertible at the option of the holder into 0.25 shares of common stock $.001 par value of the Issuer (the "Common Stock") and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's initial public offering (the "IPO"). The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's amended and restated certificate of formation (the "Charter"), in connection with the IPO. The Series C Preferred Stock had no expiration date. F1 · derivative.expiration_date: Each share of Series C Preferred Stock of Caris Life Sciences, Inc. (the "Issuer") was convertible at the option of the holder into 0.25 shares of common stock $.001 par value of the Issuer (the "Common Stock") and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's initial public offering (the "IPO"). The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's amended and restated certificate of formation (the "Charter"), in connection with the IPO. The Series C Preferred Stock had no expiration date. F1 · derivative.underlying_shares: Each share of Series C Preferred Stock of Caris Life Sciences, Inc. (the "Issuer") was convertible at the option of the holder into 0.25 shares of common stock $.001 par value of the Issuer (the "Common Stock") and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's initial public offering (the "IPO"). The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's amended and restated certificate of formation (the "Charter"), in connection with the IPO. The Series C Preferred Stock had no expiration date. F5 · ownership.nature: TSSP Sub-Fund Holdco, LLC, a Delaware limited liability company ("Sub-Fund HoldCo"), is the sole member of each of TAO SPV GP, LLC, a Delaware limited liability company ("TAO SPV"), and Empire SPV GP, LLC, a Delaware limited liability company ("Empire SPV"). TAO SPV is the managing member of each of (i) Barnett Equity Holdings, LLC; (ii) Barnett Equity Holdings II LLC; and (iii) TAO Barnett Investments LLC. Empire SPV is the managing member of TOP III Barnett Investments, LLC. F7 · ownership.nature: Sub-Fund HoldCo is managed by its sole member, whose managing member is Alan Waxman ("Mr. Waxman"). Holdco Management is managed by a board of directors, which is currently comprised of Mr. Waxman. Mr. Waxman is the CEO of Holdco Management. Each Reporting Person disclaims beneficial ownership over the reported securities herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of its or his pecuniary interest therein. Read SEC document
June 20, 2025 Filed Jun 23, 2025 20:45 UTC	Caris Life Sciences, Inc. CAI · Entity 3706	ConversionSeries C Preferred Stock · Derivative	15,527,951	$0.00	$0.00	Disclosure SEC source: 0000950170-25-089040 · ownership.xml · derivative · entry 12 TSSP Sub-Fund HoldCo LLC · CIK 0001677508 · Former 10% Owner Waxman Alan · CIK 0001515132 · Former 10% Owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Held by TOP III Barnett Investments, LLC Disclosed balance after: 0 Underlying: Common Stock · 3,881,988 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series C Preferred Stock of Caris Life Sciences, Inc. (the "Issuer") was convertible at the option of the holder into 0.25 shares of common stock $.001 par value of the Issuer (the "Common Stock") and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's initial public offering (the "IPO"). The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's amended and restated certificate of formation (the "Charter"), in connection with the IPO. The Series C Preferred Stock had no expiration date. F1 · kind: Each share of Series C Preferred Stock of Caris Life Sciences, Inc. (the "Issuer") was convertible at the option of the holder into 0.25 shares of common stock $.001 par value of the Issuer (the "Common Stock") and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's initial public offering (the "IPO"). The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's amended and restated certificate of formation (the "Charter"), in connection with the IPO. The Series C Preferred Stock had no expiration date. F1 · derivative.exercise_date: Each share of Series C Preferred Stock of Caris Life Sciences, Inc. (the "Issuer") was convertible at the option of the holder into 0.25 shares of common stock $.001 par value of the Issuer (the "Common Stock") and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's initial public offering (the "IPO"). The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's amended and restated certificate of formation (the "Charter"), in connection with the IPO. The Series C Preferred Stock had no expiration date. F1 · derivative.expiration_date: Each share of Series C Preferred Stock of Caris Life Sciences, Inc. (the "Issuer") was convertible at the option of the holder into 0.25 shares of common stock $.001 par value of the Issuer (the "Common Stock") and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's initial public offering (the "IPO"). The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's amended and restated certificate of formation (the "Charter"), in connection with the IPO. The Series C Preferred Stock had no expiration date. F1 · derivative.underlying_shares: Each share of Series C Preferred Stock of Caris Life Sciences, Inc. (the "Issuer") was convertible at the option of the holder into 0.25 shares of common stock $.001 par value of the Issuer (the "Common Stock") and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's initial public offering (the "IPO"). The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's amended and restated certificate of formation (the "Charter"), in connection with the IPO. The Series C Preferred Stock had no expiration date. F5 · ownership.nature: TSSP Sub-Fund Holdco, LLC, a Delaware limited liability company ("Sub-Fund HoldCo"), is the sole member of each of TAO SPV GP, LLC, a Delaware limited liability company ("TAO SPV"), and Empire SPV GP, LLC, a Delaware limited liability company ("Empire SPV"). TAO SPV is the managing member of each of (i) Barnett Equity Holdings, LLC; (ii) Barnett Equity Holdings II LLC; and (iii) TAO Barnett Investments LLC. Empire SPV is the managing member of TOP III Barnett Investments, LLC. F7 · ownership.nature: Sub-Fund HoldCo is managed by its sole member, whose managing member is Alan Waxman ("Mr. Waxman"). Holdco Management is managed by a board of directors, which is currently comprised of Mr. Waxman. Mr. Waxman is the CEO of Holdco Management. Each Reporting Person disclaims beneficial ownership over the reported securities herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of its or his pecuniary interest therein. Read SEC document
June 20, 2025 Filed Jun 23, 2025 20:45 UTC	Caris Life Sciences, Inc. CAI · Entity 3706	ConversionSeries C Preferred Stock · Derivative	6,884,058	$0.00	$0.00	Disclosure SEC source: 0000950170-25-089040 · ownership.xml · derivative · entry 11 TSSP Sub-Fund HoldCo LLC · CIK 0001677508 · Former 10% Owner Waxman Alan · CIK 0001515132 · Former 10% Owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Held by Barnett Equity Holdings, LLC Disclosed balance after: 0 Underlying: Common Stock · 1,721,015 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series C Preferred Stock of Caris Life Sciences, Inc. (the "Issuer") was convertible at the option of the holder into 0.25 shares of common stock $.001 par value of the Issuer (the "Common Stock") and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's initial public offering (the "IPO"). The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's amended and restated certificate of formation (the "Charter"), in connection with the IPO. The Series C Preferred Stock had no expiration date. F1 · kind: Each share of Series C Preferred Stock of Caris Life Sciences, Inc. (the "Issuer") was convertible at the option of the holder into 0.25 shares of common stock $.001 par value of the Issuer (the "Common Stock") and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's initial public offering (the "IPO"). The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's amended and restated certificate of formation (the "Charter"), in connection with the IPO. The Series C Preferred Stock had no expiration date. F1 · derivative.exercise_date: Each share of Series C Preferred Stock of Caris Life Sciences, Inc. (the "Issuer") was convertible at the option of the holder into 0.25 shares of common stock $.001 par value of the Issuer (the "Common Stock") and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's initial public offering (the "IPO"). The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's amended and restated certificate of formation (the "Charter"), in connection with the IPO. The Series C Preferred Stock had no expiration date. F1 · derivative.expiration_date: Each share of Series C Preferred Stock of Caris Life Sciences, Inc. (the "Issuer") was convertible at the option of the holder into 0.25 shares of common stock $.001 par value of the Issuer (the "Common Stock") and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's initial public offering (the "IPO"). The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's amended and restated certificate of formation (the "Charter"), in connection with the IPO. The Series C Preferred Stock had no expiration date. F1 · derivative.underlying_shares: Each share of Series C Preferred Stock of Caris Life Sciences, Inc. (the "Issuer") was convertible at the option of the holder into 0.25 shares of common stock $.001 par value of the Issuer (the "Common Stock") and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's initial public offering (the "IPO"). The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's amended and restated certificate of formation (the "Charter"), in connection with the IPO. The Series C Preferred Stock had no expiration date. F5 · ownership.nature: TSSP Sub-Fund Holdco, LLC, a Delaware limited liability company ("Sub-Fund HoldCo"), is the sole member of each of TAO SPV GP, LLC, a Delaware limited liability company ("TAO SPV"), and Empire SPV GP, LLC, a Delaware limited liability company ("Empire SPV"). TAO SPV is the managing member of each of (i) Barnett Equity Holdings, LLC; (ii) Barnett Equity Holdings II LLC; and (iii) TAO Barnett Investments LLC. Empire SPV is the managing member of TOP III Barnett Investments, LLC. F7 · ownership.nature: Sub-Fund HoldCo is managed by its sole member, whose managing member is Alan Waxman ("Mr. Waxman"). Holdco Management is managed by a board of directors, which is currently comprised of Mr. Waxman. Mr. Waxman is the CEO of Holdco Management. Each Reporting Person disclaims beneficial ownership over the reported securities herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of its or his pecuniary interest therein. Read SEC document
June 20, 2025 Filed Jun 23, 2025 20:45 UTC	Caris Life Sciences, Inc. CAI · Entity 3706	OtherCommon Stock	90,059	Not disclosed	Not disclosed	Disclosure SEC source: 0000950170-25-089040 · ownership.xml · nonDerivative · entry 10 TSSP Sub-Fund HoldCo LLC · CIK 0001677508 · Former 10% Owner Waxman Alan · CIK 0001515132 · Former 10% Owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Held by Sixth Street Specialty Lending, Inc. Disclosed balance after: 1,219,271 F4 · kind: The 2020 warrants were exercisable into Series C preferred stock at a price of $1.93 per share and into Common Stock at a price of $7.73 per share. Immediately prior to and in connection with the closing of the Issuer's IPO the 2020 warrants were exercised on a cashless basis into shares of Series C Preferred Stock which then automatically converted into Common Stock. The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO. F4 · shares: The 2020 warrants were exercisable into Series C preferred stock at a price of $1.93 per share and into Common Stock at a price of $7.73 per share. Immediately prior to and in connection with the closing of the Issuer's IPO the 2020 warrants were exercised on a cashless basis into shares of Series C Preferred Stock which then automatically converted into Common Stock. The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO. F4 · price: The 2020 warrants were exercisable into Series C preferred stock at a price of $1.93 per share and into Common Stock at a price of $7.73 per share. Immediately prior to and in connection with the closing of the Issuer's IPO the 2020 warrants were exercised on a cashless basis into shares of Series C Preferred Stock which then automatically converted into Common Stock. The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO. F6 · ownership.nature: TSSP Holdco Management, LLC, a Delaware limited liability company ("Holdco Management"), manages Sixth Street Specialty Lending Advisers Holdings, LLC, a Delaware limited liability company ("Adviser Holdings"). The business and affairs of Sixth Street Specialty Lending Advisers, LLC, a Delaware limited liability company ("Adviser"), are managed by Adviser Holdings, the sole member of Adviser. Sixth Street Specialty Lending, Inc. is managed by Adviser. F7 · ownership.nature: Sub-Fund HoldCo is managed by its sole member, whose managing member is Alan Waxman ("Mr. Waxman"). Holdco Management is managed by a board of directors, which is currently comprised of Mr. Waxman. Mr. Waxman is the CEO of Holdco Management. Each Reporting Person disclaims beneficial ownership over the reported securities herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of its or his pecuniary interest therein. Read SEC document
June 20, 2025 Filed Jun 23, 2025 20:45 UTC	Caris Life Sciences, Inc. CAI · Entity 3706	OtherCommon Stock	1,711,113	Not disclosed	Not disclosed	Disclosure SEC source: 0000950170-25-089040 · ownership.xml · nonDerivative · entry 9 TSSP Sub-Fund HoldCo LLC · CIK 0001677508 · Former 10% Owner Waxman Alan · CIK 0001515132 · Former 10% Owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Held by Barnett Equity Holdings, LLC Disclosed balance after: 5,687,176 F4 · kind: The 2020 warrants were exercisable into Series C preferred stock at a price of $1.93 per share and into Common Stock at a price of $7.73 per share. Immediately prior to and in connection with the closing of the Issuer's IPO the 2020 warrants were exercised on a cashless basis into shares of Series C Preferred Stock which then automatically converted into Common Stock. The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO. F4 · shares: The 2020 warrants were exercisable into Series C preferred stock at a price of $1.93 per share and into Common Stock at a price of $7.73 per share. Immediately prior to and in connection with the closing of the Issuer's IPO the 2020 warrants were exercised on a cashless basis into shares of Series C Preferred Stock which then automatically converted into Common Stock. The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO. F4 · price: The 2020 warrants were exercisable into Series C preferred stock at a price of $1.93 per share and into Common Stock at a price of $7.73 per share. Immediately prior to and in connection with the closing of the Issuer's IPO the 2020 warrants were exercised on a cashless basis into shares of Series C Preferred Stock which then automatically converted into Common Stock. The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO. F5 · ownership.nature: TSSP Sub-Fund Holdco, LLC, a Delaware limited liability company ("Sub-Fund HoldCo"), is the sole member of each of TAO SPV GP, LLC, a Delaware limited liability company ("TAO SPV"), and Empire SPV GP, LLC, a Delaware limited liability company ("Empire SPV"). TAO SPV is the managing member of each of (i) Barnett Equity Holdings, LLC; (ii) Barnett Equity Holdings II LLC; and (iii) TAO Barnett Investments LLC. Empire SPV is the managing member of TOP III Barnett Investments, LLC. F7 · ownership.nature: Sub-Fund HoldCo is managed by its sole member, whose managing member is Alan Waxman ("Mr. Waxman"). Holdco Management is managed by a board of directors, which is currently comprised of Mr. Waxman. Mr. Waxman is the CEO of Holdco Management. Each Reporting Person disclaims beneficial ownership over the reported securities herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of its or his pecuniary interest therein. Read SEC document
June 20, 2025 Filed Jun 23, 2025 20:45 UTC	Caris Life Sciences, Inc. CAI · Entity 3706	OtherCommon Stock	118,687	Not disclosed	Not disclosed	Disclosure SEC source: 0000950170-25-089040 · ownership.xml · nonDerivative · entry 8 TSSP Sub-Fund HoldCo LLC · CIK 0001677508 · Former 10% Owner Waxman Alan · CIK 0001515132 · Former 10% Owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Held by Sixth Street Specialty Lending, Inc. Disclosed balance after: 1,129,212 F3 · kind: The 2018 warrants were exercisable at the option of the holder into shares of Series C Preferred Stock of the Issuer at an exercise price of $1.61 per share and into Common Stock at an exercise price of $6.44 per share. Immediately prior to and in connection with the closing of the Issuer's IPO, the 2018 warrants were exercised on a cashless basis into shares of Series C Preferred Stock which then automatically converted into Common Stock. The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO. F3 · shares: The 2018 warrants were exercisable at the option of the holder into shares of Series C Preferred Stock of the Issuer at an exercise price of $1.61 per share and into Common Stock at an exercise price of $6.44 per share. Immediately prior to and in connection with the closing of the Issuer's IPO, the 2018 warrants were exercised on a cashless basis into shares of Series C Preferred Stock which then automatically converted into Common Stock. The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO. F3 · price: The 2018 warrants were exercisable at the option of the holder into shares of Series C Preferred Stock of the Issuer at an exercise price of $1.61 per share and into Common Stock at an exercise price of $6.44 per share. Immediately prior to and in connection with the closing of the Issuer's IPO, the 2018 warrants were exercised on a cashless basis into shares of Series C Preferred Stock which then automatically converted into Common Stock. The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO. F6 · ownership.nature: TSSP Holdco Management, LLC, a Delaware limited liability company ("Holdco Management"), manages Sixth Street Specialty Lending Advisers Holdings, LLC, a Delaware limited liability company ("Adviser Holdings"). The business and affairs of Sixth Street Specialty Lending Advisers, LLC, a Delaware limited liability company ("Adviser"), are managed by Adviser Holdings, the sole member of Adviser. Sixth Street Specialty Lending, Inc. is managed by Adviser. F7 · ownership.nature: Sub-Fund HoldCo is managed by its sole member, whose managing member is Alan Waxman ("Mr. Waxman"). Holdco Management is managed by a board of directors, which is currently comprised of Mr. Waxman. Mr. Waxman is the CEO of Holdco Management. Each Reporting Person disclaims beneficial ownership over the reported securities herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of its or his pecuniary interest therein. Read SEC document
June 20, 2025 Filed Jun 23, 2025 20:45 UTC	Caris Life Sciences, Inc. CAI · Entity 3706	OtherCommon Stock	2,255,048	Not disclosed	Not disclosed	Disclosure SEC source: 0000950170-25-089040 · ownership.xml · nonDerivative · entry 7 TSSP Sub-Fund HoldCo LLC · CIK 0001677508 · Former 10% Owner Waxman Alan · CIK 0001515132 · Former 10% Owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Held by Barnett Equity Holdings, LLC Disclosed balance after: 3,976,063 F3 · kind: The 2018 warrants were exercisable at the option of the holder into shares of Series C Preferred Stock of the Issuer at an exercise price of $1.61 per share and into Common Stock at an exercise price of $6.44 per share. Immediately prior to and in connection with the closing of the Issuer's IPO, the 2018 warrants were exercised on a cashless basis into shares of Series C Preferred Stock which then automatically converted into Common Stock. The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO. F3 · shares: The 2018 warrants were exercisable at the option of the holder into shares of Series C Preferred Stock of the Issuer at an exercise price of $1.61 per share and into Common Stock at an exercise price of $6.44 per share. Immediately prior to and in connection with the closing of the Issuer's IPO, the 2018 warrants were exercised on a cashless basis into shares of Series C Preferred Stock which then automatically converted into Common Stock. The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO. F3 · price: The 2018 warrants were exercisable at the option of the holder into shares of Series C Preferred Stock of the Issuer at an exercise price of $1.61 per share and into Common Stock at an exercise price of $6.44 per share. Immediately prior to and in connection with the closing of the Issuer's IPO, the 2018 warrants were exercised on a cashless basis into shares of Series C Preferred Stock which then automatically converted into Common Stock. The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO. F5 · ownership.nature: TSSP Sub-Fund Holdco, LLC, a Delaware limited liability company ("Sub-Fund HoldCo"), is the sole member of each of TAO SPV GP, LLC, a Delaware limited liability company ("TAO SPV"), and Empire SPV GP, LLC, a Delaware limited liability company ("Empire SPV"). TAO SPV is the managing member of each of (i) Barnett Equity Holdings, LLC; (ii) Barnett Equity Holdings II LLC; and (iii) TAO Barnett Investments LLC. Empire SPV is the managing member of TOP III Barnett Investments, LLC. F7 · ownership.nature: Sub-Fund HoldCo is managed by its sole member, whose managing member is Alan Waxman ("Mr. Waxman"). Holdco Management is managed by a board of directors, which is currently comprised of Mr. Waxman. Mr. Waxman is the CEO of Holdco Management. Each Reporting Person disclaims beneficial ownership over the reported securities herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of its or his pecuniary interest therein. Read SEC document
June 20, 2025 Filed Jun 23, 2025 20:45 UTC	Caris Life Sciences, Inc. CAI · Entity 3706	ConversionCommon Stock	10,103,175	Not disclosed	Not disclosed	Disclosure SEC source: 0000950170-25-089040 · ownership.xml · nonDerivative · entry 6 TSSP Sub-Fund HoldCo LLC · CIK 0001677508 · Former 10% Owner Waxman Alan · CIK 0001515132 · Former 10% Owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Held by Barnett Equity Holdings II, LLC Disclosed balance after: 10,103,175 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: Each share of Series D Preferred Stock of the Issuer was convertible at the option of the holder into 0.25 shares of Common Stock of the Issuer and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's IPO. The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO. The Series D Preferred Stock had no expiration date. F2 · shares: Each share of Series D Preferred Stock of the Issuer was convertible at the option of the holder into 0.25 shares of Common Stock of the Issuer and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's IPO. The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO. The Series D Preferred Stock had no expiration date. F2 · price: Each share of Series D Preferred Stock of the Issuer was convertible at the option of the holder into 0.25 shares of Common Stock of the Issuer and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's IPO. The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO. The Series D Preferred Stock had no expiration date. F5 · ownership.nature: TSSP Sub-Fund Holdco, LLC, a Delaware limited liability company ("Sub-Fund HoldCo"), is the sole member of each of TAO SPV GP, LLC, a Delaware limited liability company ("TAO SPV"), and Empire SPV GP, LLC, a Delaware limited liability company ("Empire SPV"). TAO SPV is the managing member of each of (i) Barnett Equity Holdings, LLC; (ii) Barnett Equity Holdings II LLC; and (iii) TAO Barnett Investments LLC. Empire SPV is the managing member of TOP III Barnett Investments, LLC. F7 · ownership.nature: Sub-Fund HoldCo is managed by its sole member, whose managing member is Alan Waxman ("Mr. Waxman"). Holdco Management is managed by a board of directors, which is currently comprised of Mr. Waxman. Mr. Waxman is the CEO of Holdco Management. Each Reporting Person disclaims beneficial ownership over the reported securities herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of its or his pecuniary interest therein. Read SEC document
June 20, 2025 Filed Jun 23, 2025 20:45 UTC	Caris Life Sciences, Inc. CAI · Entity 3706	ConversionCommon Stock	531,746	Not disclosed	Not disclosed	Disclosure SEC source: 0000950170-25-089040 · ownership.xml · nonDerivative · entry 5 TSSP Sub-Fund HoldCo LLC · CIK 0001677508 · Former 10% Owner Waxman Alan · CIK 0001515132 · Former 10% Owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Held by Sixth Street Specialty Lending, Inc. Disclosed balance after: 1,010,525 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: Each share of Series D Preferred Stock of the Issuer was convertible at the option of the holder into 0.25 shares of Common Stock of the Issuer and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's IPO. The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO. The Series D Preferred Stock had no expiration date. F2 · shares: Each share of Series D Preferred Stock of the Issuer was convertible at the option of the holder into 0.25 shares of Common Stock of the Issuer and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's IPO. The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO. The Series D Preferred Stock had no expiration date. F2 · price: Each share of Series D Preferred Stock of the Issuer was convertible at the option of the holder into 0.25 shares of Common Stock of the Issuer and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's IPO. The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO. The Series D Preferred Stock had no expiration date. F6 · ownership.nature: TSSP Holdco Management, LLC, a Delaware limited liability company ("Holdco Management"), manages Sixth Street Specialty Lending Advisers Holdings, LLC, a Delaware limited liability company ("Adviser Holdings"). The business and affairs of Sixth Street Specialty Lending Advisers, LLC, a Delaware limited liability company ("Adviser"), are managed by Adviser Holdings, the sole member of Adviser. Sixth Street Specialty Lending, Inc. is managed by Adviser. F7 · ownership.nature: Sub-Fund HoldCo is managed by its sole member, whose managing member is Alan Waxman ("Mr. Waxman"). Holdco Management is managed by a board of directors, which is currently comprised of Mr. Waxman. Mr. Waxman is the CEO of Holdco Management. Each Reporting Person disclaims beneficial ownership over the reported securities herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of its or his pecuniary interest therein. Read SEC document
June 20, 2025 Filed Jun 23, 2025 20:45 UTC	Caris Life Sciences, Inc. CAI · Entity 3706	ConversionCommon Stock	478,779	Not disclosed	Not disclosed	Disclosure SEC source: 0000950170-25-089040 · ownership.xml · nonDerivative · entry 4 TSSP Sub-Fund HoldCo LLC · CIK 0001677508 · Former 10% Owner Waxman Alan · CIK 0001515132 · Former 10% Owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Held by Sixth Street Specialty Lending, Inc. Disclosed balance after: 478,779 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each share of Series C Preferred Stock of Caris Life Sciences, Inc. (the "Issuer") was convertible at the option of the holder into 0.25 shares of common stock $.001 par value of the Issuer (the "Common Stock") and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's initial public offering (the "IPO"). The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's amended and restated certificate of formation (the "Charter"), in connection with the IPO. The Series C Preferred Stock had no expiration date. F1 · shares: Each share of Series C Preferred Stock of Caris Life Sciences, Inc. (the "Issuer") was convertible at the option of the holder into 0.25 shares of common stock $.001 par value of the Issuer (the "Common Stock") and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's initial public offering (the "IPO"). The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's amended and restated certificate of formation (the "Charter"), in connection with the IPO. The Series C Preferred Stock had no expiration date. F1 · price: Each share of Series C Preferred Stock of Caris Life Sciences, Inc. (the "Issuer") was convertible at the option of the holder into 0.25 shares of common stock $.001 par value of the Issuer (the "Common Stock") and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's initial public offering (the "IPO"). The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's amended and restated certificate of formation (the "Charter"), in connection with the IPO. The Series C Preferred Stock had no expiration date. F6 · ownership.nature: TSSP Holdco Management, LLC, a Delaware limited liability company ("Holdco Management"), manages Sixth Street Specialty Lending Advisers Holdings, LLC, a Delaware limited liability company ("Adviser Holdings"). The business and affairs of Sixth Street Specialty Lending Advisers, LLC, a Delaware limited liability company ("Adviser"), are managed by Adviser Holdings, the sole member of Adviser. Sixth Street Specialty Lending, Inc. is managed by Adviser. F7 · ownership.nature: Sub-Fund HoldCo is managed by its sole member, whose managing member is Alan Waxman ("Mr. Waxman"). Holdco Management is managed by a board of directors, which is currently comprised of Mr. Waxman. Mr. Waxman is the CEO of Holdco Management. Each Reporting Person disclaims beneficial ownership over the reported securities herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of its or his pecuniary interest therein. Read SEC document
June 20, 2025 Filed Jun 23, 2025 20:45 UTC	Caris Life Sciences, Inc. CAI · Entity 3706	ConversionCommon Stock	3,493,789	Not disclosed	Not disclosed	Disclosure SEC source: 0000950170-25-089040 · ownership.xml · nonDerivative · entry 3 TSSP Sub-Fund HoldCo LLC · CIK 0001677508 · Former 10% Owner Waxman Alan · CIK 0001515132 · Former 10% Owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Held by TAO Barnett Investments LLC Disclosed balance after: 3,493,789 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each share of Series C Preferred Stock of Caris Life Sciences, Inc. (the "Issuer") was convertible at the option of the holder into 0.25 shares of common stock $.001 par value of the Issuer (the "Common Stock") and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's initial public offering (the "IPO"). The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's amended and restated certificate of formation (the "Charter"), in connection with the IPO. The Series C Preferred Stock had no expiration date. F1 · shares: Each share of Series C Preferred Stock of Caris Life Sciences, Inc. (the "Issuer") was convertible at the option of the holder into 0.25 shares of common stock $.001 par value of the Issuer (the "Common Stock") and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's initial public offering (the "IPO"). The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's amended and restated certificate of formation (the "Charter"), in connection with the IPO. The Series C Preferred Stock had no expiration date. F1 · price: Each share of Series C Preferred Stock of Caris Life Sciences, Inc. (the "Issuer") was convertible at the option of the holder into 0.25 shares of common stock $.001 par value of the Issuer (the "Common Stock") and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's initial public offering (the "IPO"). The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's amended and restated certificate of formation (the "Charter"), in connection with the IPO. The Series C Preferred Stock had no expiration date. F5 · ownership.nature: TSSP Sub-Fund Holdco, LLC, a Delaware limited liability company ("Sub-Fund HoldCo"), is the sole member of each of TAO SPV GP, LLC, a Delaware limited liability company ("TAO SPV"), and Empire SPV GP, LLC, a Delaware limited liability company ("Empire SPV"). TAO SPV is the managing member of each of (i) Barnett Equity Holdings, LLC; (ii) Barnett Equity Holdings II LLC; and (iii) TAO Barnett Investments LLC. Empire SPV is the managing member of TOP III Barnett Investments, LLC. F7 · ownership.nature: Sub-Fund HoldCo is managed by its sole member, whose managing member is Alan Waxman ("Mr. Waxman"). Holdco Management is managed by a board of directors, which is currently comprised of Mr. Waxman. Mr. Waxman is the CEO of Holdco Management. Each Reporting Person disclaims beneficial ownership over the reported securities herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of its or his pecuniary interest therein. Read SEC document
June 20, 2025 Filed Jun 23, 2025 20:45 UTC	Caris Life Sciences, Inc. CAI · Entity 3706	ConversionCommon Stock	3,881,988	Not disclosed	Not disclosed	Disclosure SEC source: 0000950170-25-089040 · ownership.xml · nonDerivative · entry 2 TSSP Sub-Fund HoldCo LLC · CIK 0001677508 · Former 10% Owner Waxman Alan · CIK 0001515132 · Former 10% Owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Held by TOP III Barnett Investments, LLC Disclosed balance after: 3,881,988 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each share of Series C Preferred Stock of Caris Life Sciences, Inc. (the "Issuer") was convertible at the option of the holder into 0.25 shares of common stock $.001 par value of the Issuer (the "Common Stock") and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's initial public offering (the "IPO"). The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's amended and restated certificate of formation (the "Charter"), in connection with the IPO. The Series C Preferred Stock had no expiration date. F1 · shares: Each share of Series C Preferred Stock of Caris Life Sciences, Inc. (the "Issuer") was convertible at the option of the holder into 0.25 shares of common stock $.001 par value of the Issuer (the "Common Stock") and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's initial public offering (the "IPO"). The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's amended and restated certificate of formation (the "Charter"), in connection with the IPO. The Series C Preferred Stock had no expiration date. F1 · price: Each share of Series C Preferred Stock of Caris Life Sciences, Inc. (the "Issuer") was convertible at the option of the holder into 0.25 shares of common stock $.001 par value of the Issuer (the "Common Stock") and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's initial public offering (the "IPO"). The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's amended and restated certificate of formation (the "Charter"), in connection with the IPO. The Series C Preferred Stock had no expiration date. F5 · ownership.nature: TSSP Sub-Fund Holdco, LLC, a Delaware limited liability company ("Sub-Fund HoldCo"), is the sole member of each of TAO SPV GP, LLC, a Delaware limited liability company ("TAO SPV"), and Empire SPV GP, LLC, a Delaware limited liability company ("Empire SPV"). TAO SPV is the managing member of each of (i) Barnett Equity Holdings, LLC; (ii) Barnett Equity Holdings II LLC; and (iii) TAO Barnett Investments LLC. Empire SPV is the managing member of TOP III Barnett Investments, LLC. F7 · ownership.nature: Sub-Fund HoldCo is managed by its sole member, whose managing member is Alan Waxman ("Mr. Waxman"). Holdco Management is managed by a board of directors, which is currently comprised of Mr. Waxman. Mr. Waxman is the CEO of Holdco Management. Each Reporting Person disclaims beneficial ownership over the reported securities herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of its or his pecuniary interest therein. Read SEC document
June 20, 2025 Filed Jun 23, 2025 20:45 UTC	Caris Life Sciences, Inc. CAI · Entity 3706	ConversionCommon Stock	1,721,015	Not disclosed	Not disclosed	Disclosure SEC source: 0000950170-25-089040 · ownership.xml · nonDerivative · entry 1 TSSP Sub-Fund HoldCo LLC · CIK 0001677508 · Former 10% Owner Waxman Alan · CIK 0001515132 · Former 10% Owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Held by Barnett Equity Holdings, LLC Disclosed balance after: 1,721,015 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each share of Series C Preferred Stock of Caris Life Sciences, Inc. (the "Issuer") was convertible at the option of the holder into 0.25 shares of common stock $.001 par value of the Issuer (the "Common Stock") and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's initial public offering (the "IPO"). The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's amended and restated certificate of formation (the "Charter"), in connection with the IPO. The Series C Preferred Stock had no expiration date. F1 · shares: Each share of Series C Preferred Stock of Caris Life Sciences, Inc. (the "Issuer") was convertible at the option of the holder into 0.25 shares of common stock $.001 par value of the Issuer (the "Common Stock") and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's initial public offering (the "IPO"). The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's amended and restated certificate of formation (the "Charter"), in connection with the IPO. The Series C Preferred Stock had no expiration date. F1 · price: Each share of Series C Preferred Stock of Caris Life Sciences, Inc. (the "Issuer") was convertible at the option of the holder into 0.25 shares of common stock $.001 par value of the Issuer (the "Common Stock") and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's initial public offering (the "IPO"). The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's amended and restated certificate of formation (the "Charter"), in connection with the IPO. The Series C Preferred Stock had no expiration date. F5 · ownership.nature: TSSP Sub-Fund Holdco, LLC, a Delaware limited liability company ("Sub-Fund HoldCo"), is the sole member of each of TAO SPV GP, LLC, a Delaware limited liability company ("TAO SPV"), and Empire SPV GP, LLC, a Delaware limited liability company ("Empire SPV"). TAO SPV is the managing member of each of (i) Barnett Equity Holdings, LLC; (ii) Barnett Equity Holdings II LLC; and (iii) TAO Barnett Investments LLC. Empire SPV is the managing member of TOP III Barnett Investments, LLC. F7 · ownership.nature: Sub-Fund HoldCo is managed by its sole member, whose managing member is Alan Waxman ("Mr. Waxman"). Holdco Management is managed by a board of directors, which is currently comprised of Mr. Waxman. Mr. Waxman is the CEO of Holdco Management. Each Reporting Person disclaims beneficial ownership over the reported securities herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of its or his pecuniary interest therein. Read SEC document
December 17, 2024 Filed Dec 19, 2024 21:30 UTC	Sixth Street Lending Partners NONE · Entity 1805	PurchaseCommon shares of beneficial interest, par value $0.001	477,048	$29.37	$14,010,899.76	Disclosure SEC source: 0000950170-24-138484 · ownership.xml · nonDerivative · entry 2 Waxman Alan · CIK 0001515132 · Vice President 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 1,875,196 F2 · ownership.nature: Shares held directly by Sixth Street Lending Partners Advisers, LLC ("Adviser"). Adviser is managed by TSSP HoldCo Management, LLC ("Holdco Management"). Holdco Management is managed by a board of directors, which is currently comprised of Mr. Waxman. Mr. Waxman is the CEO and Managing Partner of Holdco Management. Read SEC document
December 17, 2024 Filed Dec 19, 2024 21:30 UTC	Sixth Street Lending Partners NONE · Entity 1805	PurchaseCommon shares of beneficial interest, par value $0.001	2,620,037	$29.37	$76,950,486.69	Disclosure SEC source: 0000950170-24-138484 · ownership.xml · nonDerivative · entry 1 Waxman Alan · CIK 0001515132 · Vice President 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 10,471,527 F1 · ownership.nature: Shares held directly by Sixth Street Lending Partners Note Issuer, LLC ("Note Issuer"). Note Issuer is controlled by its members, which are indirectly controlled by TAO Sutton Holdings, LLC. TAO Insurance Holdings, LLC is the managing member of TAO Sutton Holdings, LLC. A. Michael Muscolino is the managing member of TAO Insurance Holdings, LLC. Pursuant to the limited liability company agreement of TAO Insurance Holdings, LLC, Alan Waxman, as designated member of TAO Insurance Holdings, LLC has the authority to appoint the managing member of TAO Insurance Holdings, LLC. Read SEC document
September 15, 2023 Filed Sep 18, 2023 12:57 UTC	AvePoint, Inc. AVPT · Entity 746	SaleCommon Stock	7,777,746	$6.00	$46,666,476.00	Disclosure SEC source: 0001387131-23-011233 · avpt-form4_091523.xml · nonDerivative · entry 3 Sixth Street Partners Management Company, L.P. · CIK 0001812095 · Former 10% Owner Waxman Alan · CIK 0001515132 · Former 10% Owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Held by Avatar Investment Opportunities, LLC Disclosed balance after: 3,756,312 F2 · balance_after: The Contingent Consideration vests in equal thirds if the trading price of Common Stock is greater than or equal to $12.50, $15.00 and $17.50, respectively, for any 20 trading days within any 30-trading day period (the "Milestones"). If the Milestones are not met by the seventh anniversary of the closing of the issuer's initial public offering, then the unvested Contingent Consideration will be forfeited. F6 · balance_after: Includes 333,783 shares of Contingent Consideration. F7 · ownership.nature: These shares are owned directly by Avatar Investment Opportunities, LLC. Avatar Investment Opportunities, LLC's managing member is Redwood IV Finance 1, LLC, the managing member of which is Sixth Street Opportunities GenPar IV, L.P. (formerly known as TSSP Opportunities GenPar IV, L.P.). Sixth Street Opportunities GenPar IV, L.P. is ultimately indirectly controlled by Management Company. Management Company is managed by its general partner, whose managing member is Alan Waxman. F8 · ownership.nature: Each of Management Company and Alan Waxman disclaim beneficial ownership over the reported securities, except to the extent of their pecuniary interest therein. Read SEC document
September 15, 2023 Filed Sep 18, 2023 12:57 UTC	AvePoint, Inc. AVPT · Entity 746	SaleCommon Stock	3,904,714	$6.00	$23,428,284.00	Disclosure SEC source: 0001387131-23-011233 · avpt-form4_091523.xml · nonDerivative · entry 2 Sixth Street Partners Management Company, L.P. · CIK 0001812095 · Former 10% Owner Waxman Alan · CIK 0001515132 · Former 10% Owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Held by Avatar Investment Solutions 1, LLC Disclosed balance after: 1,885,806 F2 · balance_after: The Contingent Consideration vests in equal thirds if the trading price of Common Stock is greater than or equal to $12.50, $15.00 and $17.50, respectively, for any 20 trading days within any 30-trading day period (the "Milestones"). If the Milestones are not met by the seventh anniversary of the closing of the issuer's initial public offering, then the unvested Contingent Consideration will be forfeited. F4 · balance_after: Includes 167,571 shares of Contingent Consideration. F5 · ownership.nature: These shares are owned directly by Avatar Investment Solutions 1, LLC. Avatar Investment Solutions 1, LLC's managing member is TCS Finance 1, LLC, the manager of which is Sixth Street Growth GenPar, L.P. Sixth Street Growth GenPar, L.P. is ultimately indirectly controlled by Management Company. Management Company is managed by its general partner, whose managing member is Alan Waxman. F8 · ownership.nature: Each of Management Company and Alan Waxman disclaim beneficial ownership over the reported securities, except to the extent of their pecuniary interest therein. Read SEC document
September 15, 2023 Filed Sep 18, 2023 12:57 UTC	AvePoint, Inc. AVPT · Entity 746	SaleCommon Stock	4,984,140	$6.00	$29,904,840.00	Disclosure SEC source: 0001387131-23-011233 · avpt-form4_091523.xml · nonDerivative · entry 1 Sixth Street Partners Management Company, L.P. · CIK 0001812095 · Former 10% Owner Waxman Alan · CIK 0001515132 · Former 10% Owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Held by Avatar Investment Solutions (A), LLC Disclosed balance after: 2,407,123 F1 · balance_after: Includes 213,895 shares of Common Stock that the Reporting Persons have the right to receive if the trading price of the Common Stock reaches certain thresholds (the "Contingent Consideration"). F2 · balance_after: The Contingent Consideration vests in equal thirds if the trading price of Common Stock is greater than or equal to $12.50, $15.00 and $17.50, respectively, for any 20 trading days within any 30-trading day period (the "Milestones"). If the Milestones are not met by the seventh anniversary of the closing of the issuer's initial public offering, then the unvested Contingent Consideration will be forfeited. F3 · ownership.nature: These shares are owned directly by Avatar Investment Solutions (A), LLC. Avatar Investment Solutions (A), LLC's managing member is TCS Finance (A), LLC, the managing member of which is Sixth Street Growth GenPar, L.P. (formerly known as TSSP Capital Solutions GenPar, L.P.), a Delaware limited partnership. Sixth Street Growth GenPar, L.P. is ultimately indirectly controlled by Sixth Street Partners Management Company, L.P., a Delaware limited partnership ("Management Company"). Management Company is managed by its general partner, whose managing member is Alan Waxman. F8 · ownership.nature: Each of Management Company and Alan Waxman disclaim beneficial ownership over the reported securities, except to the extent of their pecuniary interest therein. Read SEC document
June 13, 2023 Filed Jun 15, 2023 20:57 UTC	AvePoint, Inc. AVPT · Entity 746	SaleCommon Stock	2,100,000	$6.16	$12,936,000.00	Disclosure SEC source: 0001387131-23-007596 · avpt-form4_061323.xml · nonDerivative · entry 3 Sixth Street Partners Management Company, L.P. · CIK 0001812095 · 10% owner Waxman Alan · CIK 0001515132 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Held by Avatar Investment Opportunities, LLC Disclosed balance after: 11,534,058 F2 · balance_after: The Contingent Consideration vests in equal thirds if the trading price of Common Stock is greater than or equal to $12.50, $15.00 and $17.50, respectively, for any 20 trading days within any 30-trading day period (the "Milestones"). If the Milestones are not met by the seventh anniversary of the closing of the issuer's initial public offering, then the unvested Contingent Consideration will be forfeited. F6 · balance_after: Includes 333,783 shares of Contingent Consideration, which were inadvertently reported as 332,552 shares in the Form 3 filed by the Reporting Persons on July 12, 2021. F7 · ownership.nature: These shares are owned directly by Avatar Investment Opportunities, LLC. Avatar Investment Opportunities, LLC's managing member is Redwood IV Finance 1, LLC, the managing member of which is Sixth Street Opportunities GenPar IV, L.P. (formerly known as TSSP Opportunities GenPar IV, L.P.). Sixth Street Opportunities GenPar IV, L.P. is ultimately indirectly controlled by Management Company. Management Company is managed by its general partner, whose managing member is Alan Waxman. F8 · ownership.nature: Each of Management Company and Alan Waxman disclaim beneficial ownership over the reported securities, except to the extent of their pecuniary interest therein. Read SEC document
June 13, 2023 Filed Jun 15, 2023 20:57 UTC	AvePoint, Inc. AVPT · Entity 746	SaleCommon Stock	1,054,277	$6.16	$6,494,346.32	Disclosure SEC source: 0001387131-23-007596 · avpt-form4_061323.xml · nonDerivative · entry 2 Sixth Street Partners Management Company, L.P. · CIK 0001812095 · 10% owner Waxman Alan · CIK 0001515132 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Held by Avatar Investment Solutions 1, LLC Disclosed balance after: 5,790,520 F2 · balance_after: The Contingent Consideration vests in equal thirds if the trading price of Common Stock is greater than or equal to $12.50, $15.00 and $17.50, respectively, for any 20 trading days within any 30-trading day period (the "Milestones"). If the Milestones are not met by the seventh anniversary of the closing of the issuer's initial public offering, then the unvested Contingent Consideration will be forfeited. F4 · balance_after: Includes 167,571 shares of Contingent Consideration, which were inadvertently reported as 166,953 shares in the Form 3 filed by the Reporting Persons on July 12, 2021. F5 · ownership.nature: These shares are owned directly by Avatar Investment Solutions 1, LLC. Avatar Investment Solutions 1, LLC's managing member is TCS Finance 1, LLC, the manager of which is Sixth Street Growth GenPar, L.P. Sixth Street Growth GenPar, L.P. is ultimately indirectly controlled by Management Company. Management Company is managed by its general partner, whose managing member is Alan Waxman. F8 · ownership.nature: Each of Management Company and Alan Waxman disclaim beneficial ownership over the reported securities, except to the extent of their pecuniary interest therein. Read SEC document
June 13, 2023 Filed Jun 15, 2023 20:57 UTC	AvePoint, Inc. AVPT · Entity 746	SaleCommon Stock	1,345,723	$6.16	$8,289,653.68	Disclosure SEC source: 0001387131-23-007596 · avpt-form4_061323.xml · nonDerivative · entry 1 Sixth Street Partners Management Company, L.P. · CIK 0001812095 · 10% owner Waxman Alan · CIK 0001515132 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Held by Avatar Investment Solutions (A), LLC Disclosed balance after: 7,391,263 F1 · balance_after: Includes 213,895 shares of Common Stock that the Reporting Persons have the right to receive if the trading price of the Common Stock reaches certain thresholds (the "Contingent Consideration"), which were inadvertently reported as 213,106 shares in the Form 3 filed by the Reporting Persons on July 12, 2021. F2 · balance_after: The Contingent Consideration vests in equal thirds if the trading price of Common Stock is greater than or equal to $12.50, $15.00 and $17.50, respectively, for any 20 trading days within any 30-trading day period (the "Milestones"). If the Milestones are not met by the seventh anniversary of the closing of the issuer's initial public offering, then the unvested Contingent Consideration will be forfeited. F3 · ownership.nature: These shares are owned directly by Avatar Investment Solutions (A), LLC. Avatar Investment Solutions (A), LLC's managing member is TCS Finance (A), LLC, the managing member of which is Sixth Street Growth GenPar, L.P. (formerly known as TSSP Capital Solutions GenPar, L.P.), a Delaware limited partnership. Sixth Street Growth GenPar, L.P. is ultimately indirectly controlled by Sixth Street Partners Management Company, L.P., a Delaware limited partnership ("Management Company"). Management Company is managed by its general partner, whose managing member is Alan Waxman. F8 · ownership.nature: Each of Management Company and Alan Waxman disclaim beneficial ownership over the reported securities, except to the extent of their pecuniary interest therein. Read SEC document
March 01, 2018 Filed Mar 5, 2018 21:13 UTC	Sixth Street Specialty Lending, Inc. TSLX · Entity 4591	PurchaseCommon Stock	1,119.5	$18.28	$20,464.46	Disclosure SEC source: 0000903423-18-000141 · waxman.xml · nonDerivative · entry 1 Waxman Alan · CIK 0001515132 · Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · See Explanation of Responses Disclosed balance after: 140,447.01 F1 · ownership.nature: TSL Advisers, LLC ("TSL Advisers") directly holds 2,732,307 shares (the "TSL Shares") of Common Stock of TPG Specialty Lending, Inc. (the "Issuer"), including 140,447.01 shares of Common Stock of the Issuer indirectly beneficially owned by Mr. Waxman (through his limited partnership interest in TSL Equity Partners, L.P., which is a member of TSL Advisers). In addition, Mr. Waxman is a member of the board of directors of TSSP HoldCo Management, LLC, the managing member of TSL Advisers and therefore may be deemed to beneficially own all of the TSL Shares. Mr. Waxman disclaims beneficial ownership of the TSL Shares except to the extent of his pecuniary interest therein. Read SEC document
November 21, 2016 Filed Nov 23, 2016 18:17 UTC	Sixth Street Specialty Lending, Inc. TSLX · Entity 4591	PurchaseCommon Stock	229.65	$18.39	$4,223.26	Disclosure SEC source: 0000903423-16-001394 · waxman.xml · nonDerivative · entry 1 Waxman Alan · CIK 0001515132 · Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · See Explanation of Responses Disclosed balance after: 139,327.38 F1 · ownership.nature: TSL Advisers, LLC ("TSL Advisers") directly holds 2,732,307 shares (the "TSL Shares") of Common Stock of TPG Specialty Lending, Inc. (the "Issuer"), including 139,327.38 shares of Common Stock of the Issuer indirectly beneficially owned by Mr. Waxman (through his limited partnership interest in TSL Equity Partners, L.P., which is a member of TSL Advisers). In addition, Mr. Waxman is a member of the board of directors of TSSP HoldCo Management, LLC, the managing member of TSL Advisers and therefore may be deemed to beneficially own all of the TSL Shares. Mr. Waxman disclaims beneficial ownership of the TSL Shares except to the extent of his pecuniary interest therein. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.